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This publication constitutes the final report for the research project ST/05/01 “Site investigations 
and disease management of the pancreas disease virus in Irish farmed salmon”, funded under the 
NDP Marine RTDI Programme. Work undertaken within the project included longitudinal 
studies of rainbow trout and Atlantic salmon at sea following the course of infection, testing for 
vectors and reservoirs of the virus, molecular studies of the virus and an epidemiological 
investigation of pancreas disease in Ireland. Results have shown that although pancreas disease 
is endemic in marine farmed Atlantic salmon, no evidence of infection in rainbow trout farmed 
at sea was found. Serological and molecular based diagnostic methods were shown to be suitable 
for the screening of fish stocks for the presence of the virus. For the confirmation of clinical 
outbreaks, farm data and histopathological results should be included. The results also suggest 
that horizontal transmission of the virus may be the main route of infection between sites. The 
project also involved the technology transfer of molecular and serological diagnostic methods for 
pancreas disease between partners and the final chapter includes practical information on 
management of, and mitigation against, pancreas disease. 
 
Pathologies such as pancreas disease, heart and skeletal muscle inflammation and 
cardiomyopathy syndrome, pose a serious threat to salmonid farming in Ireland, Scotland and 
Norway. Most significant among this group of diseases is pancreas disease, a viral disease 
affecting Atlantic salmon during the marine stage of the production cycle. From the first 
description of pancreas disease in farmed Atlantic salmon from Scotland in 1976 the disease has 
now become endemic in Ireland and parts of Norway and continues to be significant in Scotland. 
The causal agent of pancreas disease, a salmonid alphavirus, has now been characterised and a 
closely related subtype of the virus is known to cause sleeping disease in farmed rainbow trout 
on continental Europe and in the United Kingdom. The Irish salmon farming industry has 
estimated that pancreas disease has resulted in a total loss of turnover of €35 million with €12 
million loss of profit in the years 2003-2004. The economic impacts are estimated to be in the 
range of €100 million per year in Norway. In Scotland, pancreas disease and related pathologies 
are increasingly responsible for significant losses in marine salmon farms but these have yet to 
be quantified. 
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Neil Ruane, Micheal Ó Cinneide, David Graham, Hamish Rodger, Gordon Ritchie 
 
In response to the serious losses due to pancreas disease in the Irish salmon industry since 2002 
(see section 1.2 below), the Marine Institute set up a Pancreas Disease Research Group in early 
2004 to advise and suggest initiatives on research into the disease. The Institute in association 
with IFA Aquaculture, convened a seminar entitled “Pancreas Disease in Ireland and Future 
Research Priorities” in Galway, October 2004. From this meeting it became clear that pancreas 
disease was not only a problem for the Irish salmon industry, but was emerging as a significant 
problem in Norway and an international approach was needed to combat the disease.  
 
1.1 The Tri-Nation Initiative 
The Tri-Nation Initiative is a voluntary group consisting of personnel from the salmon farming 
industry, private veterinary practices, state agencies and third-level institutes from Ireland, 
Scotland and Norway. Representatives from England, France and the Faroe Islands have also 
been involved. The group allows participants to share current knowledge on pancreas disease 
and to debate future strategies for research and management of the disease. The group first 
convened at a seminar “PD: similar pathologies and prevention” in Bergen, February 2005 and 
at two follow-up seminars in Aberdeen, March 2005 and again in Bergen in May 2005. The aims 
of these seminars were to: 
 
• Share knowledge and experience on pancreas disease and diseases with a similar 
pathology. 
• Accelerate progress in developing specific control strategies. 
• Identify knowledge gaps and future research strategies. 
 
This led to the Tri-Nation Initiative being established with research and industry representation 
from each of the three countries. The group is built on four pillar activities: Steering, Research I 
(epidemiology), Research II (aetiology & longitudinal studies) & Research III (diagnostics). The 
objectives of the steering committee (Table 1.1) are: 
 
• To harness new results with the aim of accelerating progress in the development of 
specific mitigation/control strategies. 
• To encourage the presentation of new data and scientific findings to the committee 
(including industry representatives) at Tri-Nation meetings, before general release. 
• Encourage the research co-ordinators to develop projects that are integrated and 
harmonised on a Tri-Nation basis. 
 
The research working groups were responsible for drafting and submitting appropriate research 
proposals for funding in each of the Tri-Nation member countries. As a consequence of these 
efforts, eight projects on pancreas disease and diseases with similar pathologies have evolved 
under the Tri-Nation research programme umbrella, with the majority having started in January 
2006 and running for 1-4 years. Updates on these research projects and new findings have been 
presented at the regular Tri-Nation seminars held in Oslo (February 2006), Galway (September 
2006), Aberdeen (April 2007), Bergen (November 2007) and Galway (May 2008). It is planned 
that these current research projects will act as a precursor for additional and more integrated 
research proposals to the European Union under the Framework 7 and INTERREG programmes. 
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Table 1.1. Overview of the Tri-Nation Pancreas Disease Committee (2005 – 2008). 
 
Groups Ireland/N. Ireland Scotland Norway 
Steering N. Ruane (MI) 
D. Graham (AFBI) 
A. Norris (Industry) 
R. Richards (UoS) 
D. Cox (Industry) 
C. Mitchell (Industry) 
G. Ritchie (Industry) 
A. B. Olsen (NVI) 
A. Nylund (UoB) 
K. Maroni (FHL) 
Epidemiology H. Rodger (Industry) A. Murray (FRS) E. Brun (NVI) 
M. Sandberg (NSVS) 
Aetiology D. Graham 
M. McLoughlin 
(Industry) 
H. Ferguson (UoS) T. Taksdal (NVI) 
O. Brek (NVI) 
A. Nylund 
Diagnostics M. McLoughlin 
D. Graham  
D. Cox 
D. Smail (FRS) 
T. Taksdal 
Marine Institute (MI), Agri-Food & Biosciences Institute (AFBI), University of Stirling (UoS), 
Fisheries Research Services (FRS), National Veterinary Institute (NVI), University of Bergen 
(UoB), Norwegian Seafood Federation (FHL), Norwegian School of Veterinary Sciences 
(NSVS). 
 
1.2 Pancreas disease in Ireland 
Pancreas disease emerged as a significant disease of farmed salmon in Ireland in the mid-1980’s 
with 73% of marine sites affected by the disease in 1987 (Branson pers. comm., cited in 
McLoughlin et al., 1998). The disease is now considered endemic in Ireland, occurring on the 
majority of marine salmon sites each year and is the most significant infectious disease of Irish 
farmed salmon at present (Ruane et al., 2005; McLoughlin & Graham, 2007). In Ireland, the 
disease usually affects salmon in their first year at sea and for a detailed description of the 
clinical and histopathological signs of the disease the reader is referred to McLoughlin & 
Graham (2007).  
 
The first major report on the disease in Ireland was produced by Wheatley et al. (1995) using 
data collected from 11 salmon farms over the period 1988 – 1992. This study showed that 
pancreas disease was the most significant factor determining mortality in Irish farmed salmon 
during their first year at sea within that period. In fact pancreas disease accounted for 51% of the 
total mortality recorded (Wheatley et al., 1995). A collaborative project between the Irish 
Salmon Growers Association and the Veterinary Sciences Division, Queen’s University of 
Belfast developed a computerised management and disease information system for the intensive 
production of Atlantic salmon in Ireland (Menzies et al., 1996). Analysis of data from 1990 
showed that 76.5% of marine sites were affected by pancreas disease that year with mortalities 
ranging between 0 – 45%. The database was then used to study the epizootiology of pancreas 
disease in Ireland between 1989 and 1994 (Crockford et al., 1999). Throughout the study, 
pancreas disease was recorded in over 70% of the marine sites. The mean annual mortality rates 
attributed to pancreas disease fell from ca. 30% in 1989 to ca. 10% in 1994 and was attributed to 
changes in management practices introduced in 1993, primarily single generation rearing and 
fallowing (Crockford et al., 1999). 
 
The isolation of the virus causing pancreas disease (Nelson et al., 1995) resulted in the 
development of sensitive serological diagnostic tests. A serological survey of 17 marine sites in 
Ireland in 1995 showed that nine (52.9%) were antibody positive with only five of those (29.4%) 
reporting clinical signs of disease (McLoughlin et al., 1998). These studies (Crockford et al., 
1999; McLoughlin et al., 1998) indicated that the incidence and severity of pancreas disease was 
reduced in the mid to late 1990’s with estimated pancreas disease associated mortality on Irish 
farms being less than 10% in 2000 and 2001 (McLoughlin et al., 2003). In 2002 however, the 
Marine Environment and Health Series No. 34, 2008. 
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disease apparently re-emerged and 59% of Irish marine sites were affected by pancreas disease, 
with mortalities averaging 12% on affected sites (Table 1.2) (range 1 – 41%; McLoughlin et al., 
2003).  
 
Table 1.2. The prevalence and pancreas disease related mortality on Irish marine salmon sites, 
1990 - 2007. 
 
Year sites affected 
(%) 






1990 76.5 20 0 – 45 127 
1993 87 4 0 – 13 94.5 
1994 70 13.5 1 – 63 112 
2002 59 12 1 – 41 141 
2003 62 19 2 – 27  
2004 86 15 4 – 35  
2005 80 10 1 – 31 147 
2006 69 10 2 – 29 91 
2007 91 23 5 – 45  
 
The Marine Institute commissioned further studies on the epidemiology of pancreas disease in 
Ireland in 2003 and 2004 which showed that the severity of the disease had in fact increased. In 
2003, 62% of sites were affected with an average pancreas disease associated mortality of 18.8% 
(range 2 – 35%) which increased in 2004 to 86% of sites affected and 14.8% average mortality 
(range 4 – 35%; Rodger & Mitchell, 2007). The number of sites rearing salmon in Ireland 
declined in 2004, due to both economic and disease reasons and this may have had a 
confounding effect on the percentage of sites affected by pancreas disease (Rodger & Mitchell, 
2007). Over the next two years, the number of sites affected by pancreas disease remained high 
in Ireland (80% in 2005; 69% in 2006) but the average mortality associated with the disease was 
reduced to just below 10% in both years (Rodger, 2007). The prevalence of the disease increased 
again in 2007 to > 90% of marine sites with an associated mortality of 23% (Rodger, 2008). 
 
1.3 Pancreas disease in Scotland 
In Scotland the number of pancreas disease cases diagnosed in recent years has apparently 
increased, along with the geographical spread of affected sites and the associated losses. In terms 
of the actual losses (number of fish) due to suspected pancreas disease, the numbers are 
relatively low i.e. ca. 3%. When losses are calculated in terms of biomass lost, pancreas disease 
can account for 11% of losses, the most significant among all infectious diseases (Murray & 
Kilburn, 2008). Although cases of suspect pancreas disease have been recorded throughout the 
year, a peak in the number of cases occurs during August and September (Murray & Kilburn, 
2008). However, it is believed that outbreaks of pancreas disease are under-reported in Scotland 
and research initiatives into the epidemiology of pancreas disease and other diseases of similar 
pathology, such as cardiomyopathy syndrome, are currently underway.  
 
1.4 Pancreas disease in Norway 
Pancreas disease was first reported in Norway in the late 1980’s (Poppe et al., 1989) and in the 
mid-1990’s, serious outbreaks of pancreas disease were reported in Atlantic salmon and rainbow 
trout marine farms in western Norway (Olsen & Wangel, 1997; Christie et al., 1998). Prior to 
2002, the majority of pancreas disease cases were limited to the Hordaland and Sogn og 
Fjordane counties in western Norway. However, in 2003 and 2004 there were reports of the 
disease occurring in the northern counties of Nordland, Troms and Finnmark (Brun et al., 2005; 
Karlsen et al., 2006) while the number of cases within the western and south western counties 
continued to spread and increase.  

























Figure 1.2. The number of pancreas disease cases, by county, in Norway from 1995 - 2007. 
Sources: National Veterinary Institute, Norway and the Norwegian Food Safety Authority. 
 
Pancreas disease remains a problem for both sea reared Atlantic salmon and rainbow trout. The 
average time from sea transfer to outbreak of disease is approximately eight months, although 
outbreaks may be registered throughout the entire marine production phase. In Norway, pancreas 
disease can be diagnosed throughout the year, with higher numbers of cases reported between 
May and October (Olsen et al., 2007). 
 
Table 1.3. The number of Norwegian fish farms with diagnosed infectious salmon anaemia 
(ISA), infectious pancreatic necrosis (IPN), pancreas disease (PD) and heart & skeletal muscle 
inflammation (HSMI), 1998 – 2007. 
 
 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 
ISA 13 14 23 21 12 8 16 11 4 7 
IPN     174 178 172 208 207 165 
PD 7 10 11 15 14 22 43 45 58 98 
HSMI       54 83 94 162 
Data sourced from the National Veterinary Institute, Norway (Skjelstad et al., 2008). 
 
The genome of the virus causing pancreas disease in Norway has been sequenced and found to 
differ slightly from that causing pancreas disease in Ireland and Scotland and also from that 
causing sleeping disease in freshwater rainbow trout. It has therefore been termed Norwegian 
salmonid alphavirus (NSAV; Hodneland et al., 2005). Using an experimental challenge test, 
Christie et al. (2007) did not identify significant differences in the pathological, serological or 
virological responses of salmon infected with an Irish isolate and a Norwegian isolate of the 
virus. Some differences were found in a study of clinical signs and pathological findings of 
naturally occurring pancreas disease in Norway compared to findings reported for Ireland and 
Scotland (Taksdal et al., 2007). Compared with Irish outbreaks, the heart appeared to recover 
earlier and the loss of pancreatic tissues was more persistent in the reported cases. 
































Figure 1.3. A map of Norway indicating the locations of the 2007 PD outbreaks and the 
proposed PD-zone in the south-west of the country (Olsen, 2008). 
 
Since December 2007, the Norwegian authorities have made pancreas disease a List B disease, 
equivalent to List II diseases under Directive 91/67/EEC. This has led to the setting up of a 
geographical zone in the South-West of Norway within which the PD positive farms are located 
(Figure 1.3). The aim is to prevent and limit the spread of the virus, to combat the disease outside 
the zone and to prevent and control disease within the zone (Olsen, 2008).  
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2. THE SALMONID ALPHAVIRUS 
 
Neil Ruane, David Graham, Hamish Rodger 
 
2.1 The nature of the virus 
Alphaviruses belong to the family Togaviridae and currently consists of 25 species which are 
closely related in structure and molecular characteristics. Members of the genus Alphavirus are 
typically maintained in natural cycles involving transmission by an arthropod vector among 
susceptible hosts. These vectors are primarily mosquitoes, but also include mites, ticks and lice 
(Strauss & Strauss, 1994; Waarts, 2004). Alphaviruses replicate in both arthropod vectors and 
vertebrate hosts, producing a persistent lifelong infection in arthropods, while leading to an 
acute, short infection in vertebrates (Strauss & Strauss, 1994). The diversity seen within the 
alphavirus species and subtypes is believed to be influenced by host mobility (Powers et al., 
2001). Viruses that utilize reservoir hosts with limited mobility, such as small mammals, tend to 
be quite diverse and have non-overlapping distributions. The Venezuelan Equine Encephalitis 
virus complex, which primarily uses rodent hosts and a mosquito vector species with a limited 
flight range, occurs throughout the tropics, but the distributions of the various subtypes are 
discrete. The Ross River virus from Australia exhibits a similar epidemiological pattern. Viruses 
that use birds as their reservoir hosts, such as the Sindbis virus in Australia and the Western 
Equine Encephalitis virus in North America are less diverse, with each subtype occupying a 
greater geographical range (Sammels et al., 1999). The recently discovered Salmonid alphavirus 
(SAV), which has salmonid fish species as a host (Weston et al., 1999; Villoing et al., 2000a, is 
not known to have an arthropod host, although it is possible that the sea louse, Lepeophtheirus 
salmonis may play a role in the transmission of SAV (Petterson et al., 2007).  
 
Figure 2.1. A reconstruction of a typical alphavirus (Sindbis virus; Waarts, 2004). 
 
Alphaviruses are small (70 nm in diameter), spherical, enveloped viruses (Figure 2.1) with a 
genome consisting of a single strand of positive-sense RNA. The non-structural protein genes are 
encoded in the 5’ two-thirds of the genome (nsP1 – nsP4), while the structural proteins are 
translated from a subgenomic mRNA from the 3’ third of the genome (Figure 2.2). 
 
 
Figure 2.2. Organization of the Alphavirus genome with gene products and associated functions 
indicated (Powers et al., 2001). 
 
Replication occurs within the cytoplasm of the infected cell and virions mature by budding 
through the plasma membrane where the virus-encoded surface glycoproteins E2 and E1 are 
assimilated. These proteins form the basis of many diagnostic tests e.g. neutralisation assays, 
with the E2 protein being the site of most neutralising epitopes and the E1 protein containing 
more conserved, cross-reactive epitopes (Powers et al., 2001). 
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2.2 Discovery of the Salmonid alphavirus 
Nelson et al. (1995) reported the isolation of a virus from samples of pancreas disease-affected 
Atlantic salmon collected in the north-west of Ireland. The isolated virus showed 
physicochemical characteristics and morphology resembling members of the Togaviridae. 
Experimental infection of salmon post-smolts resulted in pathological changes consistent with 
pancreas disease and the authors proposed the name salmon pancreas disease virus (SPDV). In a 
follow on study, this virus was shown to be the causal agent of the disease (McLoughlin et al., 
1996), a conclusion further supported by the isolation of the virus from salmon in Norway 
(Christie et al., 1998) and Scotland (Rowley et al., 1998) affected by pancreas disease. Weston et 
al. (1999) produced cDNA clones specific to SPDV RNA and after sequence analysis identified 
the virus as the first reported alphavirus in fish. An in-depth study of the biochemical 
characteristics of the virus showed that in terms of its protein and RNA composition, SPDV 
shared many of the characteristics of animal alphaviruses (Welsh et al., 2000). At the same time, 
Villoing et al. (2000a) characterised the sleeping disease virus (SDV, see Section 2.3) as an 
alphavirus and studies showed that both diseases were associated with similar histological 
lesions of the pancreas, heart and muscle in salmon and rainbow trout (Boucher & Baudin-
Laurencin, 1996). Weston et al. (2002) showed that SPDV and SDV exhibited 91.1% nucleotide 
sequence identity over their complete genomes, with 95 and 93.6% amino acid identities over 
their non-structural and structural proteins, respectively. Virus neutralization tests performed 
with sera from experimentally infected salmon indicated that SPDV and SDV belonged to the 
same serotype. Therefore, it was proposed that SPDV and SDV were closely related isolates of 
the same virus species and the name Salmonid alphavirus was proposed (Weston et al., 2002). 
Genetic analysis of the Salmonid alphavirus from Norway revealed that it formed a distinct 
subtype, separate from both previously reported subtypes, named Norwegian salmonid 
alphavirus (Hodneland et al., 2005). Therefore classification of the virus was arranged into three 
subtypes (Hodneland et al., 2005; Weston et al., 2005; Karlsen et al., 2006): 
 
 SAV 1: causing pancreas disease in salmon in Ireland and Scotland 
 SAV 2: causing sleeping disease in freshwater rainbow trout 
 SAV 3: causing pancreas disease in salmon and marine rainbow trout in Norway 
 
Work carried out within this project now suggests that there may be up to six different subtypes 
of the virus (Fringuelli et al., 2008). See ‘Chapter 6 Virus Sequencing Studies’ for more detail. 
 
2.3 Pancreas disease diagnostics 
Diagnosing pancreas disease on marine sites is based on clinical signs, gross pathology and 
laboratory diagnostic tools and techniques including histopathology, virus isolation, serological 
tests and molecular based techniques (McLoughlin & Graham, 2007). 
 
Clinical signs associated with pancreas disease include a loss of appetite, lethargy, an increased 
number of faecal casts in the cages and increased mortality (McLoughlin et al., 2002). Affected 
fish are often unable to maintain their position in the water column due to muscle damage and 
are sensitive to any handling procedures. Prior to the isolation of the virus, histopathology was 
the main diagnostic tool for pancreas disease and still plays a major role in the study and 
diagnosis of the disease today (Murphy et al., 1992; McLoughlin et al., 2002; McLoughlin & 
Graham, 2007). The first histopathological signs are observed in the pancreas with acute necrosis 
of the pancreatic acinar cells soon after infection, closely followed by lesions in the heart. 
Skeletal muscle lesions tend to first appear 3 – 4 weeks after the appearance of pancreatic and 
heart lesions. On occasion, lesions in the kidney and brain have been observed (McLoughlin & 
Graham, 2007). 
 




Figure 2.3. An Atlantic salmon with clinical pancreas disease. Note the lack of fatty tissue 
around the pyloric caecae and the presence of faecal casts in the intestine. 
 
The first isolations of the virus used Chinook salmon embryo (CHSE-214) cells (Nelson et al., 
1995) although the development of a cytopathic effect (CPE) was slow and more difficult to 
observe. Graham et al. (2007a) compared the efficacy of a number of cell lines in isolating the 
Salmonid alphavirus. They concluded that TO and BF-2 cell lines produced the highest titres and 
the optimum temperature for virus growth was 15oC. The production of virus specific antibodies 
(Todd et al., 2001) led to the development of more specific and sensitive immunostaining 
techniques which has helped in the isolation of a greater number of virus isolates (Graham et al., 
2003a; Jewhurst et al., 2004). However there is a need for the development of more SAV-
specific antibodies to aid in the development of diagnostic tools such as ELISA tests and 
immunohistochemistry.  
 
A number of sensitive molecular techniques for detecting SAV in fish tissues and serum have 
been developed. Conventional RT-PCR methods have been described and have proven very 
useful in providing samples for sequencing of the virus (Villoing et al. 2000b; Weston et al., 
2005; Karlsen et al., 2006). More recently, real-time RT-PCR protocols have been described 
(Graham et al., 2006; Hodneland & Endresen, 2006; Christie et al., 2007). Real-time methods 
offer a rapid result without the need for post-amplification handling of amplicons, thus reducing 
risk of cross-contamination. In addition, these protocols can be further developed into 
quantitative methods which could measure viral load in samples. 
 
2.4 Diseases of similar pathology 
2.4.1 Sleeping Disease 
Sleeping disease of farmed freshwater rainbow trout, Oncorhynchus mykiss, has been observed 
in France for many years, causing mortalities of up to 22% (Boucher & Baudin-Laurencin, 
1994). The characteristic signs of the disease include the unusual behaviour of the fish ‘sleeping’ 
on their sides at the bottom of the tank. Histological observations of diseased fish show a 
chronological appearance of lesions in the pancreas, heart and finally in the skeletal muscle, 
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similar to the histopathological development of pancreas disease in salmon (Boucher & Baudin-
Laurencin, 1996). A viral aetiology of sleeping disease had been suspected as virus-like particles 
were observed in purified homogenates from kidneys of diseased fish (Boucher et al., 1994). The 
virus was first isolated by Castric et al. (1997) and fully characterised as an alphavirus by 
Villiong et al. (2000a). Historically, the disease has been endemic in parts of France with up to 
30% of trout farms in Brittany infected (Villoing et al., 2000a). A number of reports in recent 
years have shown that the disease has now spread to neighbouring countries. Sleeping disease 
was first diagnosed in rainbow trout in England and Scotland in 2002 (Branson, 2002) and 
confirmed by isolation of the Salmonid alphavirus (Graham et al., 2003b). Bergmann et al. 
(2005) reported the first isolation of the virus in Germany. The disease was also suspected to 
occur in Spain and Italy but the virus was never isolated due to a lack of diagnostic tools and the 
presence of infectious pancreatic necrosis virus. However, Graham et al. (2007b) reported the 
detection by virus isolation and/or RT-PCR of Salmonid alphavirus from rainbow trout 
exhibiting clinical signs of sleeping disease from both Spain and Italy, confirming earlier 
suspicions. 
 
2.4.2 Heart and skeletal muscle inflammation 
Heart and skeletal muscle inflammation (HSMI) is a disease of suspected viral aetiology first 
observed in Norwegian farmed salmon in 1999 (Kongtorp et al., 2004a; 2004b). The disease has 
now spread to all coastal counties between Vest-Agder and Finnmark, with 94 farms diagnosed 
with the disease in 2006 (Olsen et al., 2007). In 2007, the number of HSMI cases increased to 
162 (Skjelstad et al., 2008). A disease resembling HSMI has also been reported in farmed 
salmon in Scotland (Ferguson et al., 2005). Diagnosis of HSMI is presently based on histological 
examination, characterised by significant lesions of the heart and red skeletal muscle in the 
absence of histopathological changes in the pancreas which is considered by some groups to 
differentiate it from pancreas disease (Kongtorp et al., 2004a; McLoughlin & Graham, 2007). 
Kongtorp et al. (2004b) demonstrated that HSMI was infectious through experimental 
transmission of the disease by intra-peritoneal injection of homogenised tissue and by 
cohabitation. HSMI has been diagnosed in salmon five months after transfer to sea (Kongtorp et 
al., 2006) but can also occur in fish three weeks post-transfer or in grower fish of 5 – 6 kg (Olsen 
et al., 2007). Thus, HSMI is a condition which can affect salmon at all stages of the marine 
production cycle. Mortalities due to HSMI may be variable but the high levels of morbidity, 
which can reach almost 100%, and prolonged nature of the disease are significant problems for 
the industry (Kongtorp et al., 2006). Although a virus has been isolated from fish with clinical 
HSMI and used in experimental challenge experiments to study the disease (Eliassen et al., 
2004), no details have yet been published. Due to the increasing importance of the disease in 
Norway, the development of rapid and reliable diagnostic tools and an effective vaccine are 
major priorities for the industry. 
 
2.4.3 Cardiomyopathy syndrome 
Cardiomyopathy syndrome was first reported in farmed salmon in Norway in the mid-1980’s 
(Ferguson et al., 1990) and subsequently in Scotland (Rodger & Turnbull, 2000). The condition 
typically affects large fast-growing salmon in their second year at sea. Compared to other 
diseases, such as pancreas disease, the fish frequently die with little reported evidence of prior 
clinical disease (Ferguson et al., 1990; Brun et al., 2003). The cause of the disease is unknown, 
although the involvement of an infectious agent is suspected. CMS has a serious economic 
impact on infected farms because it affects fish late in the production cycle when the 
expenditures incurred are high (Brun et al., 2003). Although early harvesting or reduced feeding 
are practised in an attempt to combat the disease, the lack of information relating to CMS leaves 
the producers with little or no real management strategies to prevent the problem.  
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3. OBJECTIVES OF THE RESEARCH PROJECT: ST/05/01 
 
In 2002, the Marine Institute commissioned a study on the re-emergence of pancreas disease in 
the Irish farmed salmon industry (McLoughlin et al., 2003). This study had recommended that 
‘there should be a concerted national effort to continue to monitor for pancreas disease, its level 
of mortality and recording of the environmental and other livestock parameters associated with 
all farms’. Following on from this, in 2005, a call for a strategic research proposal, under the 
NDP Marine RTDI Programme was announced to further investigate the continuing threat posed 
by pancreas disease to the Irish salmon farming industry. This publication constitutes the final 
report for that research project entitled “Site investigations and disease management of the 
pancreas disease virus in Irish farmed salmon – ST/05/01”.  
 
The project was divided into the following work packages, the results of which are outlined in 
the following sections. 
• WP 1 Project Management – project coordination and integration. 
• WP 2 Longitudinal studies – sites investigations of farmed populations of salmon and 
rainbow trout. 
• WP 3 Vectors & Reservoirs – studies on the roles of mussels, sea lice and the freshwater 
phase of salmon rearing, in transmitting SAV. 
• WP 4 Virus sequencing studies – molecular sequencing of SAV isolates from Ireland. 
• WP 5 Epidemiology – a study determining the risk factors associated with pancreas 
disease outbreaks on marine sites. 
• WP 6 Management & Mitigation – information dissemination and the provision of advice 
based on the research findings.  
 
The goals of the project were: 
• To develop our understanding of how pancreas disease spreads within a site, in addition 
to the impact of infection – Chapter 4 details longitudinal studies performed on marine 
sites in Ireland. Fish were sampled before, during and after outbreaks of pancreas disease 
and the infection studied using a range of diagnostic methods.  Chapter 5 outlines testing 
performed on potential vectors and reservoirs of the virus (mussels from sea cages, sea 
lice, wild fish). Sequencing of viral isolates from Ireland and Scotland was also 
performed (Chapter 6) to gain an insight into the diversity of the virus and to provide 
information on the means of spread of SAV between farms.  
• To better understand the epidemiological factors which contribute to the introduction of 
SAV to a site – a detailed epidemiological study of the 2005 and 2006 year class of 
salmon is outlined in Chapter 7. 
• To build national capacity in the area of screening and to establish early warning 
systems for pancreas disease – during the project, technology transfer of diagnostic 
methods took place between Queens University Belfast and the Marine Institute.  The 
Fish Health Unit at the Marine Institute now has expertise in serological and molecular 
based methods for the diagnosis of pancreas disease in fish serum and tissues. 
• To develop management tools and provide advice on mitigating factors for industry 
practitioners and veterinarians – the results of the study have been collated and 
management practices for mitigating pancreas disease are outlined in Chapter 8. 
• To communicate the research findings to the Irish and European aquaculture industries – 
throughout the project, results were presented at project meetings, PD Tri-Nation Group 
meetings and at international conferences such as the European Association of Fish 




Marine Environment and Health Series No. 34, 2008. 
_______________________________________________________________________________________________________ 
 11
4. LONGITUDINAL STUDIES (WP 2) 
 
David Graham, Elena Fringuelli, Claire Wilson, Helen Rowley, Amanda Brown, Laura Murchie, 
Louise Totten, Eugene Casey, Karen McCrann, William Ward, Leo Foyle, Lorraine McCarthy, 
Neil Ruane 
 
A series of longitudinal studies were planned within the project, with the intention of targeting 
S0 and S1 populations of salmon and also rainbow trout reared in seawater. The principle goals 
of this work package were to compare and contrast disease outbreaks in the different populations 
in terms of rates of spread, levels and duration of infection and the performance of different 
diagnostic tests, including virology, serology and real time RT-PCR, with a view to better 
understanding their relative strengths and weaknesses. All of the study sites were chosen on the 
basis of their previous histories of pancreas disease infection. In each study, sampling protocols 
and frequencies were agreed in advance with the farms. Details of the sampling protocol are 
shown in Appendix II. 
 
4.1 Rainbow trout. 
A longitudinal study was initiated on Eany Fish Farm, Donegal on 27th January 2006. This farm 
had previously seen significant problems with pancreas disease in salmon, but not in trout, 
farmed side by side. An extensive range of samples including tissues and blood from 20 fish, 
mussels and water were collected. Sampling was conducted at fortnightly intervals, except as 
dictated by weather or management requirements. The site also held S1 salmon. Therefore the 
sampling program was extended to include these also, although typically at 4-weekly intervals. 
Sampling continued until 14th June 2006, when the study was terminated as most of the fish had 
been harvested. 
 
Sera were routinely tested on receipt in the laboratory for the presence of virus neutralizing 
antibodies or the SAV itself. Positive results on these tests would be used as evidence of 
infection and justify the time and expense of testing all of the samples collected using a wider 
range of techniques. However all of the samples tested negative, indicating that neither the 
salmon nor the rainbow trout populations had been challenged during the trial period. 
 
A second longitudinal study was initiated on a population of rainbow trout that went to sea on 
28th June 2006. The first samples were collected on 25th July 2006, with sampling scheduled for 
three week intervals. No salmon were on the site from this time forward, so only rainbow trout 
were sampled. Sampling and serological/virological testing continued until harvest the following 
summer, with the last samples collected on 20th April 2007. 
 
Once again, no evidence of infection was found in this study. The reason for this is unknown. 
However, when the studies commenced, this was the only stocked fish farm in Donegal Bay. It is 
possible that the absence of stock from other farms in the Bay broke a cycle of infection whereby 
naïve fish going to sea were exposed to challenge from sick or recovered fish on other sites, with 
continual cycling of infection within the Bay. Evidence in support of this horizontal spread is 
presented below in this work package, and also in Chapter 6. 
 
4.2 Atlantic salmon S1’s. 
Atlantic salmon of Fanad origin were transferred to the Hawk’s Nest site of the Mannin Bay 
Salmon Company, Clifden, Co. Galway in April 2006. The average weight of these fish was 67g. 
One cage (H7), containing 30,000 fish, was selected as a sentinel cage for the duration of the 
study. Six other cages, holding an initial total of 214,500 S1’s were also present on site. The 
Hawk’s Nest site has a previous history of pancreas disease and it was anticipated that the 
sentinel fish would be exposed to the salmonid alphavirus from the production fish comrades or 
environment, in the same and surrounding cages, in natural conditions, until the end of the trial. 
This site experienced a pancreas disease infection from August to November 2005 during a 
similar trial involving Marine Harvest family fish (Ruane et al., 2005).   




At each sample date twenty fish were removed from the sentinel cage and placed in a bin of 
water containing MS-222 for transport to the farm laboratory. Prior to dissection, fish were 
weighed and measured. Fish were sampled for histology, virology, serology (Graham et al., 
2003a) and molecular diagnosis by real-time RT-PCR (Hodneland & Endresen, 2006). When 
possible, wild fish, sea lice and mussels from the cage were also taken for SAV detection by 
real-time RT-PCR. Additional information on the water temperature, cage mortalities and cause 
of death were also recorded throughout the study. A description of the sampling protocol is 
shown in Appendix II. 
 
4.2.2. Results 
Fish weight, water temperature & mortality levels 


























































Figure 4.1. Growth of the sentinel Atlantic salmon used in the Mannin Bay study (April 2006 – 
August 2007). Fish were moved to the grower site in April 07. 
 
The weekly mortalities and water temperature levels for the entire Hawk’s Nest site are shown in 
Figure 4.2. The initial peak of mortality seen from week 9 – 16 (June and July) is primarily due 
to pancreas disease. A second minor peak was observed from week 19 – 25 (August) which was 
attributed to changes in the water quality and an increase in phytoplankton in the Bay. After 




































Figure 4.2. Weekly mortalities and water temperature at Hawk’s Nest (April 2006 – April 2007). 
 mortalities; ■ temperature (oC). 
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The causes of death of the mortalities were classified during the period of April to October 2007. 
Mortalities were classified according to the cause of death in the following manner: I Bird 
damage; II Seal Damage; III Runt; IV Chronic PD; V Acute PD; VI Decomposed; VII Other. 
Pancreas disease was first diagnosed on site on the 25th of May, seven weeks after transfer to sea 
(Figure 4.7). The greatest cause of death was from predator damage (bird and seal) accounting 
for 44% of the observed mortality. Pancreas disease accounted for 34% in total (Figure 4.3). It is 
possible that a percentage of the mortalities due to predators were in fact fish suffering from 

















Figure 4.3. A breakdown of the cause of death of fish in the sentinel cage at the Hawk’s Nest 
site from April 2007 – October 2007. 
 
Histology 
The first histopathological signs of pancreas disease were found on May 25th with acute necrosis 
of the exocrine pancreas and grade I necrosis of cardiomyocytes being observed. No signs of 
infection were seen in the muscle tissue at this stage. By June 6th, pancreatic acinar tissue was 
partially or totally absent from a number of fish. Necrosis was now observed in the heart and the 
red and white muscle tissues. By June 13th, severe histopathological changes were observed in 
almost all fish. In addition to this, hepatic pyknosis or inflammation consistent with a viral 
infection was also observed. A large number of sloughed enterocytes were observed in the 
caecae. 
 
Histopathological changes associated with pancreas disease were observed until July 18th. At this 
time, a low level of necrotic acinar cells was observed in a small number of fish. Large numbers 
of inflammatory cells were observed in the myocardium and pancreatic fat suggesting that an 
immune response had been mounted against the infection. After this time, no significant changes 
associated with pancreas disease were observed for the remainder of the study, apart from 
chronic inflammation of the pancreatic fat in a number of fish on August 29th. The histological 
findings are summarised below in Figure 4.4.  
 














































Figure 4.4. Histopathological changes in the sentinel fish during a natural outbreak of pancreas 
disease at Hawk’s Nest.  pancreatic necrosis;  cardiomyopathy;  red muscle necrosis;  
white muscle necrosis. 
 
Testing of sera for virus-neutralizing antibodies and virus. 
The first virus-positive sera were detected on May 25th (coinciding with the first 
histopathological observations) with virus positive sera also detected on June 6th, but not 
thereafter. When using real-time RT-PCR to detect virus in the serum, positive samples were 
detected as early as May 8th with one positive fish also being detected on July 5th. Antibody 
positive fish were found on June 6th with the number of antibody positive fish increasing to 
>90% by June 20th. Antibodies were consistently found in the serum of 60 – 70% of the fish 
tested throughout the study even up to August of the following year (prior to harvesting), almost 








































Figure 4.5. The percentage of fish positive for SAV using virus isolation on serum (), real-time 
RT-PCR () and the percentage of antibody-positive sentinel fish() at Hawk’s Nest. 
 
Real-time RT-PCR 
Heart, kidney, gill and brain tissue samples were removed from each fish during the longitudinal 
study and tested for the presence of SAV by a real-time RT-PCR procedure described by 
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Hodneland & Endresen (2006). All four tissues were first found to be positive for viral RNA on 
May 25th coinciding with the first histopathological signs and detection of the virus by isolation 
in cell culture. Although all four tissues were found to be positive throughout most of the 
sampling period, heart and gill tissues gave the highest level of virus positive samples in the 
study suggesting that these tissues are the most suitable for detection of fish previously exposed 
to the Salmonid alphavirus. Positive tissues were detected in a sample of fish taken in February 
2007 but not at the next sampling in August 2007, prior to harvest, indicating that tissues can 
















































Figure 4.6. The percentage of sampled fish positive for SAV by real-time RT-PCR during the 
Hawk’s Nest longitudinal study; heart (), kidney (), gill () and brain (). 
 
Virus isolation 
A selected number of samples taken for virology were tested for virus by inoculating the 
supernatant from the tissue homogenates on Epithelioma papulosum cyprini (EPC) and bluegill 
fry fibroblast (BF-2) cell lines. Inoculated cultures were incubated at 15oC for 7 days before 
subcultivation onto fresh EPC and BF-2 cell monolayers for a further 7 days. RNA was extracted 
from the second-passage infected cell cultures using TRIzol® Reagent (Invitrogen) and used in a 
real-time RT-PCR assay for SAV as described by Hodneland & Endresen (2006). 
 
After the second passage, aliquots of the cell culture media removed from the 24-well plates 
were inoculated onto fresh EPC and BF-2 cell monolayers on 96-well plates for a further 7 days. 
Detection of the Salmonid alphavirus was performed using an immunostaining method 
previously described by Graham et al. (2003a) using the monoclonal antibody 2D9 raised against 
SAV strain F93-125 (Todd et al., 2001). 
 
The results are summarized in Table 4.1 below. The first positive samples detected by virus 
isolation were on May 25th and confirmed by using the real-time RT-PCR assay.  
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Table 4.1. Results of virus isolation, from tissue homogenates, of SAV on EPC and BF-2 cell 
lines. Data is shown as the number of positive wells out of three replicates after staining with a 
specific monoclonal antibody or as a positive or negative result by real-time RT-PCR. 












1 25-04-06 1 0/3 NEG 0/3 NEG 
2 25-04-06 1 0/3 NEG 0/3 NEG 
3 25-04-06 1 0/3 NEG 0/3 NEG 
4 25-04-06 1 0/3 NEG 0/3 NEG 
55 25-05-06 30 3/3 POS 2/2 POS 
58 25-05-06 30 3/3 POS 3/3 POS 
66 25-05-06 30 IPNV+ POS IPNV+ POS 
68 25-05-06 30 3/3 POS 3/3 POS 
85 6-06-06 42 3/3 POS 3/3 POS 
88 6-06-06 42 2/3 POS 3/3 POS 
94 6-06-06 42 3/3 POS 0/3 POS 
95 6-06-06 42 3/3 POS 1/3 POS 
147 5-07-06 71 3/3 POS 0/3 POS 
148 5-07-06 71 1/3 POS 0/3 POS 
149 5-07-06 71 0/3 NEG 0/3 POS 
150 5-07-06 71 0/3 NEG 0/3 POS 
213 15-08-06 112 0/3 NEG 0/3 POS 
214 15-08-06 112 0/3 NEG 0/3 NEG 
218 15-08-06 112 0/3 NEG 0/3 NEG 
223 15-08-06 112 0/3 NEG 0/3 NEG 
261 12-09-06 140 0/3 NEG 0/3 NEG 
265 12-09-06 140 0/3 NEG 0/3 NEG 
269 12-09-06 140 0/3 NEG 0/3 NEG 
270 12-09-06 140 0/3 NEG 0/3 NEG 
286 3-10-06 161 0/3 NEG 0/3 NEG 
295 3-10-06 161 0/3 NEG 0/3 NEG 
302 3-10-06 161 0/3 NEG 0/3 NEG 
303 3-10-06 161 0/3 NEG 0/3 NEG 
314 21-11-06 210 0/3 NEG 0/3 NEG 
315 21-11-06 210 0/3 NEG 0/3 NEG 
316 21-11-06 210 0/3 NEG 0/3 NEG 
317 21-11-06 210 0/3 NEG 0/3 NEG 
337 16-01-07 266 0/3 NEG 0/3 NEG 
344 16-01-07 266 0/3 NEG 0/3 NEG 
346 16-01-07 266 0/3 NEG 0/3 NEG 
348 16-01-07 266 0/3 POS 0/3 NEG 
 




An overview of the mortality figures in the sentinel cage and the key dates are shown in Figure 
4.7. Pancreas disease was first confirmed on the site in a sample taken on May 25th 
simultaneously by histopathology, serology, virus isolation and by molecular methods, seven 
weeks after transfer of the sentinel fish to sea. The earliest indication of infection was the 
detection of virus-positive serum by real-time RT-PCR on May 8th just four weeks after transfer 
to sea. This contrasts to the disease outbreak of 2005, when pancreas disease was first suspected 
on the site on July 25th and confirmed on August 16th. In both cases, fish were transferred to sea 
in April (2005 and 2006).  
 
In this study, the peak of mortalities due to pancreas disease occurred from mid-June until late 
July and is consistent with the histopathology results which show very little PD-associated 
changes after August 1st. Interestingly, viraemic sera were only found by isolation in cell culture 
on May 25th and June 6th suggesting a transient infection of the blood or low virus levels below 
the detection limit of the assay. Using a more sensitive molecular based assay, viraemic sera 
were detected over a slightly longer period, from May 8th up to July 5th (Figure 4.5).  
Nonetheless, virus was detectable in serum for a much shorter period than was found for a range 
of tissues by RT-PCR (Figures 4.5, 4.6). This indicates that viraemia is a transient event present 
only in the early stages of infection in an individual fish. Where infection moves through a cage 
rapidly, as was seen in this case, the same holds true at the population level. In such cases, the 
detection of viraemia may therefore be interpreted as current, active infection, whereas detection 
of viral RNA by RT-PCR in tissues could indicate either current disease or be indicative of a 
historical infection from exposure to virus that took place some months previously. The presence 
of clinical signs or findings from additional tests such as histopathology or testing of serum for 
virus can help distinguish between these two possibilities. 
 
The long persistence of a detectable signal by RT-PCR in a range of tissues, particularly heart 
and gill, in this study is consistent with earlier findings from an experimental study (Christie et 
al., 2007) and suggests that these fish are carriers with a persistent or latent infection which 
poses a risk to naïve populations going to sea alongside recovered populations. This hypothesis 
is supported by findings from molecular strain typing on this site. The study population 
overlapped with a recovered population on this farm. Typing of the strains from both populations 
indicated that they were indistinguishable. This is consistent with the study population being 
infected from the recovered population and would explain the rapidity with which infection was 
acquired post transfer. Evidence from other sites also supports this local transmission of virus. If 
this hypothesis is correct, it has clear implications in terms of mitigation and control, with a 
requirement to avoid overlapping of naïve and recovered populations in time and space. 
Fallowing alone, which only addresses the persistence of infection in the environment and on 
equipment, would therefore be expected to be of limited use, particularly in bays with multiple 
sites. 
 
Seroconversion was first detected on June 6th and the number of antibody positive fish increased 
throughout June, July and into August. Seropositive fish were still found in a sample taken in 
August of the following year just prior to harvesting of the fish. This would suggest that fish 
which have recovered from pancreas disease remain immune to reinfection for the remainder of 
the marine production cycle. 
 
Between the period of April – October 2006, it was estimated that 34% of the mortalities in the 
sentinel cage were due to pancreas disease (compared with 75% in 2005; Ruane et al., 2005). 
However, 44% of the mortalities in this period were classified as being caused by predators 
(birds and seals) and it is likely that the majority of these fish were suffering from pancreas 
Pancreas disease in farmed salmon-health management and investigations at Irish farm sites 2005-2008 
_______________________________________________________________________________________________________ 
 18
disease. Thus the figures for cause of death are likely to underestimate the real number of 
pancreas disease related mortalities.   
 
 
Figure 4.7. An overview of the weekly mortalities expressed as a percentage of the population in 
the sentinel cage during the pancreas disease longitudinal study. 
 
1. Virus positive serum first detected in week 4 by molecular diagnosis. 
2. First histopathological signs of disease recorded. First tissues tested positive for virus by 
molecular methods. 
3. First seropositive fish detected. 
4. Last recording of pancreas disease histopathological signs. 
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5. VECTORS & RESERVOIRS (WP 3) 
 
David Graham, Elena Fringuelli, Claire Wilson, Helen Rowley, Sarah Culloty, 
Stephen McCleary, Neil Ruane 
 
As described above, other alphaviruses of humans and other mammals have an epidemiology 
that typically involves an invertebrate vector such as mosquitoes in the transmission of infection. 
The identities of possible vectors and reservoirs of infection for SAV that may play a key role in 
introducing and maintaining infection on sites remain unknown. Within the project, emphasis 
was placed on the role of sea lice and mussels as possible invertebrate vectors. The approach 
proposed, as described in more detail below, centred on the collection of field samples during 
longitudinal studies coupled with an experimental infection of mussels. In addition, the relative 
importance of vertical (from parent to offspring) transmission relative to horizontal transmission 
were unknown.  
 
The aims of this work package were therefore as follows: 
• Conduct an experimental infection of mussels and test the samples to evaluate their role 
as a possible carrier species. 
• Test lice/mussels from salmon farms for the presence of SAV as considered appropriate 
based on results of experimental/field studies. 
• Test salmon broodstock in freshwater for SAV and the subsequent testing of their 
progeny throughout the culture cycle. 
• Test wild fish for the presence of SAV. 
 
5.1 Experimental infection of mussels. 
An experimental infection of mussels (Mytilus edulis) was conducted in collaboration with the 
Department of Zoology, Ecology & Plant Sciences (ZEPS), University College Cork (UCC). It is 
possible that SAV may be detected in mussels due solely to bioaccumulation as a result of the 
feeding process. This is distinct from actual infection of the mussels, where the virus is capable 
of infecting tissues and replicating therein, resulting in production of new virus particles which 
can be transmitted onward to initiate new infections. The aim of this work was therefore to 
determine the level and duration of bioaccumulation of SAV or of the ability of the virus to 
actively replicate in the mussels. The experimental study was conducted over a 20 day period 
using wild mussels from County Cork. The mussels were brought into tanks and acclimatised to 
the hold conditions in seawater at 10ºC.  
 
Five hundred mussels (Mytilus edulis) were obtained from Fastnet Mussels, Bantry on the 26th 
June 2007. The animals were allowed to acclimatise to a constant temperature of 10ºC over a ten 
day period. Mussels were held in aerated 50L aquaria in a constant temperature room throughout 
the study. Control and experimental tanks were kept separate. Animals were deemed healthy as 
no mortalities occurred and they continued to open their shells and filter during this period. The 
animals were fed on Phytoplex algal solution each day to ensure that filtration continued. 
 
A sub-sample of 20 mussels was removed after this acclimation period on the day before 
challenge (D-1). Hepatopancreas (HP) and gill (G) were removed from each individual and 
separate samples placed in RNAlater® and maintenance medium. These samples were then 
screened for SAV by real time RT-PCR to confirm the absence of adventitious infection or 
contamination, with negative results. The trial was conducted using SAV strain F02-143, isolated 
from marine Atlantic salmon in Connemara in 2002. The virus was grown in TO cells, and had 
an initial titre of 107.05 TCID50/ml. 
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For exposure to the virus, experimental animals (approximately 240) were placed in an aerated 
tank containing 3 L of seawater (enough to cover the shells and allow filtering to continue). A 30 
ml volume of viral solution was added, giving a final concentration of 106.0 TCID50/ml and the 
animals were exposed for 24 hours.  Previous experimental studies have shown that the half life 
of virus at 10ºC in seawater is >4 days (Graham et al., 2007c). Control animals (160) were 
placed in 3 L of water and 30 ml of control medium added and exposure also continued for 24 
hours. During this time mussels in both groups were observed to have their shells opened and 
were filtering. After this time period both groups were washed in clean seawater (in separate 
systems) and placed in tanks of clean aerated seawater. Two control tanks were set up with 80 
mussels each and three experimental tanks with 80 animals each. Animals were fed daily on 
Phytoplex and the trial continued for a period of 20 days. 
 
Twenty experimental animals and 10 control animals were removed on days 1, 2, 3, 5, 7, 14 and 
20 days post-exposure. Two samples of gills and hepatopancreas were removed from each 
animal and individually placed in RNAlater® (for subsequent RT-PCR testing) and maintenance 
medium (for subsequent virus isolation).  Samples of gills and hepatopancreas in maintenance 
medium were stored at -80ºC.  Samples in RNAlater® were stored at -20 ºC. The trial was 
terminated after 20 days of exposure. 
 
Samples were initially tested for the presence of SAV by real time RT-PCR, a highly sensitive 
technique which detects the presence of the viral genetic material (RNA). Samples are tested 
over 40 reaction cycles. The lower the cycle number at which a sample becomes positive (the CT 
value), the higher the relative level of RNA present in the initial sample. None of the control 
samples tested positive. In the exposed mussels, 40% of gill samples (Figure 5.1) and 60% of 
hepatopancreas samples (Figure 5.2) were positive at day 0 (i.e. immediately after challenge). On 
day 1, these figures had declined to 20% and 10% respectively. Samples from gills on days 2, 3, 
5 and 7 were all negative. On days 2 and 3, 20% and 10% of hepatopancreas samples were 
positive. All hepatopancreas samples tested on days 5 and 7 were negative. CT values in both 
gills and hepatopancreas were consistently high (Figures 5.1 and 5.2), suggesting low levels of 
RNA present. Testing was conducted on 10 mussels from the exposed group on days 0, 1, 2, and 
3. 20 mussels were tested on days 5 and 7. Either 5 or 10 control mussels were tested on each of 
these days. Based on these initial findings, no further testing was carried out. 
 
The results indicate that under the trial conditions used the mussels did not become infected with 
SAV, with subsequent replication of the virus. Rather, the short duration of positivity, associated 
with high CT values, is consistent with the positive signals detected being due to 
bioaccumulation/contamination of the shellfish with virus during the initial exposure, with 
subsequent leaching/decay rapidly resulting in negative results. In conclusion, the results suggest 
that mussels are not a reservoir for SAV infection for farmed salmon. Based on these results, no 
testing of field samples was conducted. 


























Figure 5.1. Real time RT-PCR results for gill tissues from mussels (Mytilus edulis) 
























Figure 5.2. Real time RT-PCR results for hepatopancreas tissues from mussels (Mytilus edulis) 
experimentally exposed to SAV (•) and unexposed controls (), showing the mean CT values of 
positive shellfish. 
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5.2 Testing sea lice 
During the course of the S1 longitudinal study (Section 4.2), lice were collected from farmed 
salmon on a number of occasions. These were received as either individual lice or pools 
collected on the same day. The numbers of lice submitted were limited, reflecting in part the low 
numbers of lice present at some sampling points. These were tested for SAV by real time RT-
PCR. Details of lice tested and results are shown below (Table 5.1). 
 
Table 5.1. Details of real time RT-PCR testing of lice for SAV from S1 longitudinal study. 
Case ref Sample ref Date Single or pool Result 
F06-236 3165 27/07/06 Single Neg 
F06-236 3175 01/08/06 Single Neg 
F06-236 3207 12/09/06 4 pools of 5 lice Neg 
F06-236 3218 03/10/06 4 pools of 5 lice Neg 
F06-281 - 21/11/06 4 pools of 5 lice Neg 
 
Based on these results, no testing of lice from other sites was carried out. It is recognised that the 
lice available for testing were largely collected some time after infection occurred in the study 
population (May/June). Therefore, it is likely that there were few or no viraemic fish present 
when the tested samples were collected. The precise role of lice in the epidemiology of SAV 
infection therefore remains to be clarified, and would be worthy of further study in future work. 
Indeed, SAV has recently been reported by RT-PCR in lice in a Norwegian study (Petterson et 
al., 2007). 
 
5.3 Vertical transmission and broodstock testing. 
At the start of the project, the possibility of there being a freshwater reservoir of infection in 
salmon, based on vertical transmission from broodstock through eggs, milt and reproductive 
fluids, had been proposed. Studies were therefore designed to explore the significance of this in 
the Irish context. An initial sampling of broodstock was conducted at Fanad (Marine Harvest 
Ireland) in December 2005. Based on an agreed sampling protocol, serum, tissues and milt or 
ovarian fluid (n = 67) were collected from broodstock. Sera were subjected to serological and 
virological testing. Heart tissue and reproductive fluids were tested by real time RT-PCR. Four 
sera were found to contain neutralizing antibodies. None were viraemic. All tissues and 
reproductive fluids also tested negative. 
 
Fish derived from this broodstock population also served as the basis for subsequent longitudinal 
studies. These were sampled several times in freshwater (FW) and bloods tested for evidence of 
antibodies or virus. Part of this population went to sea in November 2006 as S0 fish, while the 
remainder went to sea as S1 fish in spring 2007. Details of the FW testing are given in Table 5.2 
below.  
 
Table 5.2. Details of FW testing of Fanad fish for SAV and associated antibodies. 
REFERENCE DATE No. fish Antibody pos Virus pos 
F06-12032 25/08 20 0 0 
F06-14312 19/10 19 0 0 
F06-15253 09/11 20 0 0 
F07-4501 16/03 20 0 0 
 
Additional testing of juveniles in freshwater was carried out on other sites, based on routine 
surveillance samples. In total, 80 sera from 7 separate submissions were tested for virus and 
antibody, with negative results. 
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In December 2006, a further round of broodstock testing was conducted at Fanad. This time a 
total of 100 female broodstock were sampled, with blood, ovarian fluids, and heart tissue 
collected. Virus neutralizing antibodies were detected in 14 sera, while none of the sera were 
viraemic. All of the ovarian fluids and hearts tested negative by real time RT-PCR for SAV. 
Based on these results, no evidence for broodstock infection/vertical transmission was found.  
 
It is concluded that vertical transmission is not an important feature of the epidemiology of SAV 
infections in salmon farming in Ireland. Rather, fish seem to acquire infection during the marine 
phase of production, either from other farmed salmon, or from an as yet unidentified 
carrier/reservoir host(s). This finding is consistent with the results of molecular studies described 
in Chapter 6. 
 
5.4 Wild fish testing. 
Marine fish 
As part of the S1 longitudinal study (see Section 4.2) a small number of fish were caught by rod 
and line near the sentinel cage during the period of the pancreas disease outbreak. In total, 
kidney, heart and gill tissues were removed from one mullet and 11 mackerel and placed in  
RNAlater® for subsequent analysis by real-time RT-PCR. All samples tested negative which 
would suggest that these fish species do not transmit the virus, particularly as analysis of these 
tissues from salmon give positive results for up to 12 months after infection. However the 
number of fish sampled was very small and future studies should focus on a larger sample size 
and test a greater number of fish species. 
 
Freshwater fish 
As part of a study investigating the health status of wild freshwater fish, the Fish Health Unit 
screened over 1,200 fish from eight rivers in 2007. Tissue samples (in pools of five) were tested 
for the Salmonid alphavirus using conventional virological methods using EPC and BF-2 cell 
cultures. No evidence of SAV was found. In addition to this, gill tissue was taken from each fish 
and stored in RNAlater® for subsequent analysis by real-time RT-PCR. A number of samples 
from one river gave a positive reading and an illustration of a retesting of ten positive samples is 
shown below in Figure 5.3. 
 
Work is currently ongoing to amplify the product and have it sequenced which will be necessary 
in order to show that the samples are actually positive for the Salmonid alphavirus. 
 
Wild fish potentially play an important role in the epidemiology of a number of important fish 
viral diseases, such as infectious salmon anaemia (Raynard et al., 2001; Plarre et al., 2005) and 
infectious pancreatic necrosis (Wallace et al., 2008). It is therefore highly probable that a wild 
fish reservoir for the Salmonid alphavirus exists and a comprehensive monitoring of wild fish 
should be initiated in order to determine if the virus is limited to salmonid species or if other fish 
species are involved. As the virus is also the causal agent of sleeping disease in rainbow trout in 
freshwater, detection of the virus in freshwater would appear to be possible. Nylund et al. (2003) 
detected the Norwegian subtype of the salmonid alphavirus in freshwater farmed Atlantic salmon 
suffering from haemhorrhagic smolt syndrome. At this stage the prevalence of the virus in wild 
stocks is unknown and the risk, if any, to aquaculture facilities remains to be quantified. As the 
virus was not isolated in these samples but only detected by real-time PCR, this would indicate 
that the levels were extremely low and may represent a natural background level in wild fish.






Figure 5.3.  Graphic presentation of ten gill tissue samples from freshwater brown trout tested for 
the salmonid alphavirus by real-time RT-PCR. The samples with the lowest Ct values (ca. 18 and 
25 are positive controls). Gill tissues show Ct values from 27 – 32. 
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6. VIRUS SEQUENCING STUDIES (WP 4) 
 
Elena Fringuelli, David Graham 
 
At the start of the project, only limited published genome sequence data was available for SAV. 
Such information has allowed the degree of variation between viruses to be studied. This has 
important implications for areas such as vaccine efficacy, virus virulence, ability to trace the 
source of outbreaks and the design of diagnostic tools. From previous work carried out at the 
AFBI laboratory a large library of viruses was available for examination, primarily from salmon 
in Ireland, but also from other species (rainbow trout) and countries (England, Scotland, France, 
Italy, Spain). This library, complemented by further isolates made during this study and from 
other routine diagnostic work in the laboratory, formed the basis of this work package. 
 
Initial work concentrated on the design of the sequencing reactions to be used. The focus of these 
studies was to identify the most variable (and therefore informative) regions of the genome using 
available data from subtypes 1, 2 and 3, and then to develop RT-PCR assays to amplify these 
genome segments. These studies showed regions of nsP3 and E2 (non-structural and structural 
proteins respectively) to be the most variable, with nucleotide variability of up to 25.1% and 
12.3% between strains respectively. Primers were therefore designed and assays developed to 
amplify 490 and 516bp products of nsP3 and E2 respectively. These assays were then used to 
generate sequence data from a total of 48 strains. Details of these are given in Table 6.1. 
 
Table 6.1. Details of virus strains used in the sequencing study.  
 Virus Year Country Company farm Source Species Mort. rate nsP3 E2F93-125 1993 Ireland A 1 CHSE-214 cells AS na AJ316244 AJ316244
F-2111(1) 2002 Ireland A 1 serum AS na EF675503 EF675551
F91-115 (A3) 1991 Ireland A 1 serum AS na EF675515 EF675563
F91-116 (P1-6) 1991 Ireland A 1 serum AS na EF675516 EF675564
F04-44 (10) 2004 Ireland B 2 serum AS 15% EF675514 EF675560
F06-186 (5) 2006 Ireland B 3 serum AS na EF675517 EF675561
F03-123 (3) 2003 Ireland C 4 serum AS 18% EF675500 EF675548
F04-183 (A1) 2004 Ireland C 5 serum AS 23% EF675511 EF675559
F05-118 (5) 2005 Ireland C 6 serum AS 15% EF675510 EF675558
F06-227 (20) 2006 Ireland D 7 serum AS < 5% EF675506 EF675554
F05-27 (13) 2005 Ireland D 8 serum AS 20% EF675507 EF675555
F 1045/96 1996 Ireland D 9 CHSE-214 cells AS na EF675499 EF675547
F06-182 (55) 2006 Ireland E 10 serum AS na EF675501 EF675549
F05-184 (5) 2005 Ireland E 11 serum AS na EF675502 EF675550
F05-238 (9) 2005 Ireland E 12 serum AS < 5% EF675505 EF675553
F06-43 (4) 2006 Ireland E 13 serum AS 10% EF675508 EF675556
F02-194 (11) 2002 N. Ireland F 14 serum AS na EF675504 EF675552
F05-190 (38) 2005 Ireland G 15 serum AS 35% EF675509 EF675557
F05-294 (3) 2005 Ireland H 16 serum AS 6% EF675512 EF675562
F03-209 (3) 2003 Scotland I serum AS na EF675513 EF675565
F06-243 (4) 2006 Scotland I 17 serum AS 0% EF675518 EF675566
F06-17 (9) 2006 Scotland I 18 serum AS 9% EF675521 EF675568
F07-02 2007 Scotland I 19 serum AS na EF675522 EF675571
F06-241(1) 2006 Scotland I 20 serum AS 0% EF675524 EF675572
F06-267(9) 2006 Scotland I 21 serum AS 0% EF675526 EF675574
F06-290 (6) 2006 Scotland I 22 serum AS <1% EF675534 EF675582
F06-290 (8) 2006 Scotland I 23 serum AS < 1% EF675535 EF675583
F06-139 (33) 2006 Scotland L 24 serum AS 15% EF675519 EF675569
F06-93 (37) 2006 Scotland L 25 serum AS < 15% EF675520 EF675567
F06-41 (54) 2006 Scotland L 26 serum AS < 15% EF675523 EF675570
F04-224 (17) 2004 Scotland M 27 serum AS < 5% EF675525 EF675573
F05-310 (10) 2005 Scotland M 28 serum AS < 5% EF675527 EF675575
F05-310 (18) 2005 Scotland M 29 serum AS < 5% EF675528 EF675576
F05-124 (5) 2005 Scotland M 27 serum AS < 5% EF675529 EF675577
S49p 1995 France CHSE-214 cells RT na AJ316246 AJ316246
EE37 France heart RT na EF675530 EF675578
VF03 (p4) 2002 France CHSE-214 cells RT na EF675531 EF675579
F02-85 (9) 2002 Scotland CHSE-214 cells RT na EF675532 EF675580
F06-119 (7) 2006 Scotland serum RT na EF675536 EF675581
F04-212 (5) 2004 England serum RT na EF675537 EF675585
F02-67 (18) 2002 England serum RT na EF675533 EF675584
F04-08 (6) 2004 Spain serum RT na EF675538 EF675586
F04-08 (18) 2004 Spain serum RT na EF675539 EF675587
F04-198 (29) 2004 Italy serum RT na EF675540 EF675588
F05-105 (12) 2005 Italy serum RT na EF675541 EF675589
F04-198 (22) 2004 Italy serum AS na EF675542 EF675590
SavH20/03 2003 Norway heart/kidney AS na AY604235 AY604235
SavH10/02 2002 Norway CHSE-214 cells AS na AY604236 AY604236
PD97-N3 1997 Norway CHSE-214 cells AS na AY604237 AY604237
SavSF21/03 2003 Norway heart/kidney AS na AY604238 AY604238
F04-170 (6) 2004 Norway serum AS na EF675543 EF675591
F04-170 (8) 2004 Norway serum AS na EF675544 EF675592
F04-170 (3) 2004 Norway serum AS na EF675545 EF675593
F04-170 (7) 2004 Norway serum AS na EF675546 EF675594
accession  number
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The sequence data generated for the two gene segments, along with published data for reference 
strains were then used to construct phylogenetic trees to examine the relatedness of the strains 















































Figure 6.1. Phylogenetic relationship between SAV strains based on nucleotide sequence 
comparisons of an nsP3 gene fragment. Percentages of bootstrap values are given at each node. 
















































































































































































Figure 6.2. Phylogenetic tree showing phylogenetic relations between salmonid alphaviruses 
strains based on nucleotide sequence comparisons of E2 gene fragment. Percentages of bootstrap 
values are given at each node. Branch lengths are informative and drawn to scale.  
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There was good agreement between both trees, with the classification of each strain remaining 
consistent within both clusters. Examination of these data revealed a number of new findings. 
• Firstly, the study identified three previously unrecognised subtypes of the virus based on 
the clustering of strains. These have been designated subtypes 4, 5 and 6 (SAV4, SAV5, 
SAV6).  
• SAV4 was found in Ireland and Scotland. Strains 91-115 and 91-116 (from 1991) came 
from archived field material held by AFBI. These are the oldest strains from which 
sequence data is available. It is noteworthy that these strains are from the same farm in 
Donegal where the reference strain of virus (F93-125) was isolated in 1993. F93-125 is a 
subtype 1 virus, demonstrating the presence of two different subtypes on the farm in a 
two year period.  
• SAV5 was found in Scotland only. 
• SAV6- only one isolate (F/1045/96) fell into this new subtype. This came from an 
outbreak of PD in Connemara in 1996.  
• Prior to this study, SAV2 had only been reported from rainbow trout in freshwater. For 
the first time, SAV2 was detected in marine farmed salmon on one site in Scotland. 
Follow-up work, has since demonstrated the presence of SAV2 on another Scottish 
salmon farm, plus identified an old (1990s) Scottish isolate as SAV2, indicating that this 
subtype has been present for some time. This suggests that the freshwater cases may have 
derived from a marine source.  
• SAV2 strains were also confirmed in farmed FW rainbow trout in Spain and Italy during 
the course of this work. This discovery formed the basis of a published paper (Graham et 
al. 2007b). This is consistent with a single/limited introduction of infection into 
freshwater, with subsequent dissemination within the industry, including the UK, where 
it was first reported in 2002. 
 
Further analyses of strains by location indicated that in Scotland, SAV subtypes 2, 4 and 5 were 
present (Figure 6.3; subsequent work has also revealed the presence of SAV1). In Ireland SAV1 
and SAV4 predominate, with the single isolation of SAV6 also, although this has not been 
detected recently. It was evident that SAV4 isolates were restricted to Donegal, whereas SAV1 
strains were concentrated in Connemara. 
 
The data were considered in two ways for evidence in support of either horizontal or vertical 
transmission. Firstly, where clusters of strains with identical or very similar sequences were 
found, evidence of geographical clustering was looked for. This was evident in several instances 
(strains within dotted circles, Figure 6.3). This data showed that in a number of locations, 
including Mannin Bay, Mulroy Bay, Kilkieran Bay and the Hebrides, there was clustering of 
related/identical strains over time on different farms and even between different companies. This 
provides strong circumstantial evidence for local horizontal circulation of these strains between 
farms over several years, either through the water or by other means. In several cases where this 
was investigated further, evidence indicated that populations of recovered and naïve fish had 
been in the water together in these locations, suggesting that the former may have served as the 
ultimate source of infection for the latter. This is supported by the findings of the longitudinal 
surveys, where persistence of viral RNA for extended periods of time was demonstrated 
(Chapter 4). 
 
In addition, analysis of strains from Kilkieran Bay showed the presence of multiple isolates with 
identical sequences (Figures 6.1, 6.2, 6.3). The sources of input fish for these sites were either 
Scotland or Donegal. If infection had been introduced vertically, it would logically be expected 
that the strains present would reflect those predominant in the areas from where the fish were 
sourced. This is clearly not the case in this instance. This data has been accepted for publication 
(Fringuelli et al., 2008). 
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In conclusion, the results from this work package have considerably extended our knowledge on 
the variability of SAV strains and the epidemiology of infection. This work in turn raises a 
number of issues that require further consideration. These include: 
• Impact of sequence variability on diagnostic tools (serological, virological, molecular). 
• Impact of strain subtypes on vaccine efficacy. 
• Transmission routes of infection between farms. 
• Investigation of wildlife (vertebrate or invertebrate) reservoirs of infection. 
• Application of molecular epidemiology as an aid to outbreak investigations and 
identification of risk factors that could support control/mitigation. 
 
                   
 
                   
Figure 6.3. Distribution of Scottish and Irish isolates by subtype and location. Those within 
dotted circles are clustered phylogenetically.(Background image courtesy NASA (www.nasa.gov )) 
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7. EPIDEMIOLOGY (WP5) 
 
Hamish Rodger, Susie Mitchell, Albert Girons, Tracy Clegg, Simon More. 
 
In the present work data from two generations of salmon at sea (2005 and 2006) have been 
analysed. For selected variables, data from four different generations (2003, 2004, 2005 and 
2006) have been used to test for significant associations. This study builds on those 
investigations previously reported (McLoughlin et al., 2003, Rodger & Mitchell, 2007). 
 
7.1 Materials & Methods 
Survey population 
Populations targeted for this study were commercially reared Atlantic salmon (Salmo salar) from 
farm sites in the northwest, west and the southwest of Ireland. Two subsequent generations were 
sampled: 2005 year-class, fish hatched in early 2004 that went to sea in late 2004 as S0s and in 
early 2005 as S1s, as well as 2006 year-class, fish hatched in early 2005 that went to sea in late 
2005 as S0s and early 2006 as S1s. 
 
Collection of data 
Data was collected using a detailed questionnaire for each site. The questionnaire consisted of 
open ended and closed questions covering a number of areas. Information on the stock was 
collected including fish number, date of transfer at sea, fish weight at time of PD outbreak, 
stocking density, strain of fish and smolt type. Management information gathered involved 
whether fallowing was employed, feeding rate prior to and during an outbreak of PD, whether 
fish were moved during their life cycle, existence of other PD-positive sites in the same bay and 
vaccination history. Information on PD and other diseases was also collected, including time of 
outbreak of PD (where appropriate), number of days from transfer to sea to PD outbreak, number 
of weeks to reach peak mortality, number of weeks PD present in site, as well as percentage of 
mortality caused by specific disorders, PDV vaccination status (for 2005 year-class), average lice 
levels during production cycle, previous history of PD in the site, estimated loss of growth due to 
PD and site geographical region and proximity to a fish processing plant. Environmental data 
such as seawater temperature during the whole production cycle was also gathered.  
 
Diagnosis of PD 
A farm was categorised as positive for PD where there had been a diagnosis of the clinical 
disease with laboratory test confirmation, i.e. veterinary examination with recording of typical 
clinical signs plus either PD histopathology and/or the detection of salmonid alphavirus (SAV) 
through virus isolation or SAV antibodies. The start date for an outbreak of PD on each site was 
taken as the date when clinical signs were first observed. The end date for an outbreak was taken 
as the date when mortalities returned to background levels and clinical signs of PD were no 
longer observed. Where a farm was confirmed with PD, the estimated loss of growth due to PD 
was given as the percentage of thin, poor condition fish in the pens that were, as a result, 
downgraded at harvest. 
 
Water temperatures 
A water temperature profile for the whole production cycle was put together for each site for 
2005 and 2006. Marine Institute water temperature figures were used when available. In those 
cases where this data was not available, farm records were used. The water temperature profile 
for each farm was used to calculate the water temperature at the time of a PD outbreak, as well 
as the number of days that fish were exposed to water temperatures between 10 and 15ºC after 
the diagnosis of PD.  
 




Sea lice (Lepeophtheirus salmonis and Caligus elongatus) burdens on farmed salmon are 
monitored regularly in each generation of fish at all marine sites in Ireland. Each population is 
inspected at least monthly by Marine Institute staff and these figures were used for the purposes 
of this study. 
 
Feeding rate 
Farm records supplied the feeding rate data, which was expressed as a percentage of body 
weight, in the month prior to confirmation of a PD outbreak and these were assessed in relation 
to PD mortality levels.  
 
Data analysis 
Data was summarised, entered and sorted into different categories using Microsoft Excel. Due to 
the nature of the data and the small sizes, non-parametric statistic tests were used for most of 
analysis of the collected data. SPSS, Version 5 (SPSS Inc., Chicago, IL) was the statistical 
software used. For categorical data (occurrence and impact of PD, smolt type, fallowing, history 
of PD, livestock movement, strain, bay and company) a percentage of inputs was calculated for 
each variable in relation to either PD status (positive or negative) and PD impact (high impact 
when mortality ≥10%, versus low impact, when mortality <10%). Significance in relationships 
between groups was assigned when P < 0.05 in all analysis. Odds ratios were calculated for 
variables in relation to occurrence of PD. Fisher’s Exact Test was used to determine any 
significant differences. Continuous variables (stocking densities, time to outbreak, temperature at 
PD outbreak, feeding rate, and days at 10 - 15ºC risk window) were analysed using Wilcoxon 
Two sample test.  
 
7.2 Results 
Number of inputs and fish 
Information was gathered from 29 separate populations of salmon at sea from two different 
generations or year-classes. The 2005-year class was constituted by 15 inputs, while 2006-year 
class included information from 14 different inputs. The number of salmon that went to sea is 
summarised in Table 7.1. 
 
Table 7.1. Number of study populations and fish going to sea by smolt type. 
Year No. of S0s 
populations  
(No. of fish) 
No. of S1s 
populations  
(No. of fish) 
Total inputs  
(No. of fish) 
2005 6 (1771197) 9 (3638276) 15 (5409473) 
2006 6 (1936087) 8 (3675828) 14 (5611915) 
2005 & 2006 12 (3707284) 17 (7314104) 29 (11021388) 
 
These figures represent all the marine salmon farms in Ireland which transferred fish to sea from 
autumn 2004 to spring 2006. Basic farm data was collated from all marine sites. However, more 
detailed records with regard to feeding rates, weights, mortality numbers, etc. were not available 
for a low number of farms. 
 
Incidence of PD 
In 2005, 12 out of 15 (80%) populations reported PD outbreaks. For 2006, one of the farms had 
an unknown PD status and 9 out of 13 (69%) farms reported PD outbreaks. The average total 
mortality due to all diseases was 34.8% (range 16% to 90%) for 2005 and 34.7% (range 10.5% 
to 100%) for 2006. Mortality due to PD on affected farms was 9.8% (range 0.7% to 31%) for 
2005 and 9.6% (range 2.1% to 29%) for 2006.  In addition to mortalities due to PD, the 
percentage of runts due to PD was 2.8% (range 1.6% to 7.5%) for 2005 and 1.7% (range 2%-
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14%) for 2006. Average weight of a fish at the time of PD outbreak was 764g in 2005 and 660g 
in 2006. When fish were differentiated by smolt type, average body weight for 04 S0s was 960g 
(range 282-1681g) and 1134g (range 334-2200g) for 05 S0s. For 2006 year-class average body 
weight for 05 S1s was 635g (range 202-1120g) and 283g (range 138-484g) for 06 S1s. The 
number of operating sites, percentage of sites that reported a PD outbreak, and percentage of 
mortality due to PD for the period 2002 to 2006 are featured in Figures 5 and 6. Total and PD-
mortality figures for 2005 and 2006 year-class by smolt type in comparison with data from 2003 



































Figure 7.1. The number of smolt inputs (bars) and the percentage of PD positive sites (line) in 


































Figure 7.2. Number of fish going to sea (), number of fish which died because of PD () and 
average percentage of mortality due to PD () during the period 2002-2007. 
 


















Figure 7.3. Total mortality () and PD-specific mortality () for 2003, 2004, 2005 and 2006 
year-class detailed by smolt type. 
 
Seasonality 
The month that outbreaks occurred in 2005 and 2006 varied between sites, with more than half 
of the outbreaks (63%) occurring between June and November (Figure 7.4). When examining 
data for the last five years, there is a higher concentration of number of cases in early summer 
















Figure 7.4. A breakdown of the month when PD was first diagnosed in each of the sea sites for 
2005 and 2006 by smolt type;  2004 S0;  2005 S1;  2005 S0;  2006 S1. 
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Figure 7.5. The month when PD was first diagnosed in Ireland during the period 2002 to 2006. 
 
Duration of PD outbreaks 
In 2005, the average time that fish spent at sea from transfer to PD outbreak was 243 days (range 
116-423 days) and 174 days (range 72-263 days) in 2006. The average time for an affected farm 
to reach peak or highest mortalities in an outbreak was 15 weeks (range from 1 to 32 weeks) in 
2005 and 5 weeks (range 3 to 6) in 2006 after the first signs of disease. The average time that PD 
persisted as a problem in a site was 21 weeks (range 12 to 32 weeks) in 2005 and 13 weeks 
(range 6 to 20 weeks) in 2006. Mortality patterns often followed a bell-shaped distribution, 
consistent with the infectious nature of the disease.  
 
Water temperatures 
A water temperature profile was produced for every site for 2005 and 2006 using data collected 
by the Marine Institute or the farm itself. Temperature measurements were done between 5 and 
10 metres of depth. It was a common feature for years 2005 and 2006 to get water temperatures 
over 10ºC during the second half of April or early May and over 15ºC in early/mid July. During 
August water temperatures could drop some days below 15ºC in some sites. It was not until the 
second half of September or early October that water temperatures consistently dropped below 
15ºC and it was not until late November, or early December in some sites, that water 
temperatures dropped below 10ºC.  
 
Main causes of mortality 
Total mortality figures for the 2005 and 2006 generations were recorded by cause of mortality. 
Gill problems were the group of disorders causing the highest percentage of mortality in the Irish 
salmon industry [2005: 15.8% (range 1.4% to 89%) and 2006: 15.1% (range: 2% to 85%)]. PD 
was the most significant infectious disease in terms of mortality during the study period. The 
main causes of mortality for each generation are represented in Figures 7.6 and 7.7. 
 






















































Figure 7.6. Average mortality due to specific causes for all marine Atlantic salmon stocks in 




























































Figure 7.7. Average mortality due to specific causes for all marine Atlantic salmon stocks in 
Ireland in 2006. 
 
7.3 Data analysis 
Data from 2005 and 2006 generation have been analysed. When possible, data from a total of 
four different generations (2003, 2004, 2005 and 2006) have been used to test for any 
statistically significant differences in terms of occurrence of PD and its impact (high impact for 
PD mortality levels ≥10% and low impact for PD mortality levels <10%). For the purpose of the 
analysis of univariate statistics, all sites and years were assumed to be independent. In order to 
give a better idea of strength of relation between a variable and occurrence or impact of PD, odds 
ratio was calculated for those categorical variables with p-values that were significant or close to 
significant. Special attention to water temperatures was taken following the recommendations 
from a previous study (Rodger & Mitchell, 2007). 
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7.3.1. CATEGORICAL DATA ANALYSIS 
Occurrence and impact of PD between different generations 
In 2003, 14 PD outbreaks were reported out of 21 (67%) different inputs of salmon. In 2004, 12 
out of 14 (86%) different populations suffered PD. In 2005, the proportion of inputs that suffered 
PD was 12 out of 15 (80%), and in 2006 it was 9 out of 13 (69%) in 2006. There has been 
limited variation in the percentage of sites affected by PD and this was not significantly different 
between these four different years (Fisher’s exact, P = 0.583). The percentage of farms having 
high impact of PD was also not significantly different between these four different generations 
[2003 = 11/14 (79%), 2004 = 6/12 (50%), 2005 = 6/12 (50%) and 2006 = 4/9 (44%). Fisher’s 
exact, P = 0.287]. 
 
Smolt type 
Data from 4 different generations of salmon (2003 to 2006) was taken into account. Twenty out 
of 23 inputs (87%) of S0 salmon and 27 out of 40 inputs (68%) of S1 salmon reported PD 
outbreaks. No statistically significant differences were found (Fisher’s exact test, P = 0.133). In 
terms of PD impact, borderline differences were found (OR = 3.56, Fisher’s exact test, P = 
0.072). 8 out of 20 populations of S0 PD-affected fish (40%) suffered high impact of PD, while 
19 out of 27 populations of S1 PD-affected fish (70%) presented with high impact outbreaks. 
 
Fallowing 
Use of fallowing in these four generations of salmon at sea was analysed. No statistically 
significant differences were found in terms of PD occurrence or impact. A total of 37 out of 47 
(79%) farms using fallowing were PD-positive and 10 out of 16 (63%) farms not using fallowing 
were PD-positive (Fisher’s exact, P = 0.319). Twenty two out of 37 (60%) farms using fallowing 
had high impact of PD and 5 out of 10 (50%) farms not using fallowing had high impact of PD 
(Fisher’s exact, P = 0.723). 
 
History of PD 
Borderline differences in terms of occurrence of PD were found between sites with or without 
previous history of PD in 2003, 2004, 2005 and 2006 (40 out of 50 sites (80%) with previous 
history of PD suffered PD and 13 out of 25 sites (52%) with no previous history of PD suffered 
PD (OR = 3.43, Fisher’s exact, P = 0.075)). No statistically significant differences were found 
for impact of PD between both groups (24 out of 40 sites (60%) with previous history of PD 
suffered high impact of PD and 2 out of 7 sites (29%) with no previous history of PD suffered 
high impact of PD (Fisher’s exact, P = 0.118)). 
 
Livestock movement 
Highly significant differences were found in percentage of PD affected inputs between groups of 
fish that were and were not moved during the production cycle in 2003, 2004, 2005 and 2006 (34 
out 38 (90%) inputs that were moved during the production cycle had a PD outbreak and 13 out 
of 25 (52%) inputs that were not moved during the production cycle had a PD outbreak (OR = 
7.85, Fisher’s exact, P = 0.001)). No statistically significant differences were found in terms of 
PD impact: 19 out of 34 (56%) inputs that were moved during the production cycle suffered high 
impact of PD and 8 out 13 (62%) inputs that were not moved during the production cycle 
suffered high impact of PD (Fisher’s exact, P = 1.00).  
 
Strain 
Data from 2003 to 2006 and data from 2005 and 2006 only were used to compare occurrence of 
PD and impact of PD between a total of 4 different strains of salmon. No statistically significant 
differences were found. Results are illustrated in Table 7.2. 
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Table 7.2. Percentage of inputs that suffered PD and high impact of PD for 2003 to 2006 period 
and only for 2005 and 2006. 
 03, 04, 05 and 06 data 05 and 06 data 
STRAIN % PD P % High mortality P 
% 
PD 
P % High 
mortality 
P 
X 80 0.213 68 0.089 75 1 58 0.387
All other 
types 
63  33  75  33  
Y 62 0.076 56 1 69 0.67 33 0.387
All other 
types 
84  58  80  58  
Z 75 1 67 1 75 1 67 0.586
All other 
types 
75  57  75  44  
Other 80 1 50 1 67 1 50 1 
All other 
types 
74  58  76  47  
 
 
Bay and company 
Data collected from 2003, 2004, 2005 and 2006 generation of salmon going to sea was used to 
calculate percentage of inputs per bay and per company that were PD-positive, and which 
proportion of them suffered a high impact of PD (Table 7.3 and 7.4). Interpretation of 2003 to 
2006 data for PD presence demonstrated a significant association with company (P= 0.01) and 
bay (P = 0.02). No statistically significant differences were found between companies and bays, 
in terms of PD presence and impact, using 2005 and 2006 data.  
 
Table 7.3. PD outbreaks and its impact per company 
03,04,05,06 generation  05 and 06 generation 
Company % PD +ve % high 
impact 
inputs % PD +ve % high 
impact 
Inputs 
A 67 50 3 100 0 1 
B 100 100 4 100 100 2 
C 0 0 1 - - - 
D 0 0 1 - - - 
E 33 100 3 0 0 1 
F 80 50 5 67 50 3 
G 100 50 4 100 0 2 
H 83 47 23 73 50 11 
I 100 57 7 100 50 4 
J 50 100 2 0 0 1 
K 0 0 2 - - - 
L 50 50 4 67 50 3 
M 50 0 2 - - - 
 Pr = < P 
0.0111 
Pr = < P 
0.7261 
Total=61 Pr = < P 
0.3961 
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Table 7.4. PD outbreak and its impact per bay 
03,04,05,06 generation  05 and 06 generation 
Bay % PD +ve % high 
impact 
inputs % PD +ve % high 
impact 
Inputs 
N 100 0 1    
O 57 50 7 75 33 4 
P 100 80 5 100 67 3 
Q 20 100 5 0 0 1 
R 33 0 3    
S 82 56 11 67 25 6 
T 100 100 4 100 100 2 
U 100 100 1    
V 0 0 1    
W 100 67 6 100 50 4 
X 77 38 17 63 40 8 
 Pr = < P 
0.0208 
Pr = < P 
0.2677 
Total=61 Pr = < P  
0.4607 




Table 7.5. Categorical data statistical analysis results from 2003, 2004, 2005 and 2006 
generation of salmon at sea 
 % PD P % High mortality P 
SMOLT     
S0 87 0.133 40 0.072 
S1 68  70  
YEAR     
2003 67 0.583 79 0.287 
2004 86  50  
2005 80  50  
2006 69  44  
FALLOWING     
Yes 79 0.319 60 0.723 
No 63  50  
HISTORY OF PD    
Yes 80 0.075 63 0.118 
No 54  29  
LIVESTOCK  MOVEMENT    
Yes 90 0.001 60 1.000 
No 52  62  
 
Table 7.6. Categorical data statistical analysis results from 2005 and 2006 generation of salmon 
at sea 
 % PD P % High mortality P 
SMOLT     
S0 73 1 25 0.183 
S1 77  62  
YEAR     
2005 80 0.67 50 1 
2006 69  44  
 
Marine Environment and Health Series No. 34, 2008. 
_______________________________________________________________________________________________________ 
 39
7.3.4. CONTINUOUS DATA ANALYSIS 
 
Input number 
No statistically significant differences were found when numbers of fish transferred to sea in 
each input from autumn 2002 to spring 2006 were compared (average for PD-positive sites = 
361629 and average for PD-negative sites = 255500. Wilcoxon two sample test, P = 0.347). 
However, highly statistically significant differences were found when average input numbers of 
PD-positive and PD-negative sites for only 2005 and 2006 generation were compared (PD-
positive = 378201 and PD-negative = 191328. Wilcoxon two sample test, P = 0.008). Significant 
differences in average input number were also found between populations that suffered high and 
low impact of PD from 2003, 2004, 2005 and 2006 generation (high impact = 450000 and low 
impact = 271344, Wilcoxon two sample test, P = 0.049). No statistically significant differences 
were found when the same was done with PD-positive populations from 2005 and 2006 




Two different measurements from four different generations of fish (2003 to 2006) were used to 
evaluate stocking densities: fish/m2 and kg of fish/m3. Significant statistical differences were 
found in average stocking densities (kg of fish/m3) at time of PD outbreak and average stocking 
densities at a similar time of PD-negative populations (6.4 kg/m3 in PD positive sites and 2.9 
kg/m3 in PD-negative sites (Wilcoxon two sample test, P = 0.016). No statistically significant 
differences were found when average stocking densities in terms of fish/m2 from PD-positive 
and PD-negative sites at a similar time were compared (85 fish/m2 in PD positive sites and 124 
fish/m2 in PD-negative sites. Wilcoxon two sample test, P = 0.146). Average stocking densities 
from populations that suffered high and low impact of PD were compared. No statistically 
significant differences were found (high impact 90.1 fish/m2 and low impact 65 fish/m2. 
Wilcoxon two sample test, P=0.101. High impact = 6.2 fish/m3 and low impact = 6.6 kg fish/m3. 
Wilcoxon two sample test, P=0.468).  
 
Days to outbreak 
Populations from four different generations (2003 to 2006) that suffered from PD were used to 
calculate average number of days from transfer to sea until first signs of PD appeared. No 
statistically significant differences were found between groups of high and low impact of PD 
(high impact = 134 and low impact = 264. Wilcoxon two sample test, P = 0.256). The same 
occurred when data from 2005 and 2006 was used (high impact = 128 and low impact = 253, 
Wilcoxon two sample test, P = 0.244). 
 
Feeding rate 
Average feeding rates (% body weight) 4 weeks prior to detection of PD were compared between 
populations of salmon that suffered high and low impact PD between 2003 and 2006. No 
statistically significant differences were found between them (high mortality = 1.1 and low 
mortality = 0.9. Wilcoxon two sample test, P = 0.35).  
 
Current speeds 
No statistically significant differences were found when current speeds from PD-positive and 
PD-negative populations, as well as current speeds from high and low PD-impact sites were 
compared (PD-positive = 38.6 cm/s and PD-negative = 10 cm/s, Wilcoxon two sample test, 
P=0.170. High impact = 47.5 cm/s and low impact = 38.5 cm/s. Wilcoxon two sample test, P = 
0.457).  
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Temperature at time of PD outbreak 
No differences were found between average temperatures at time of PD outbreak for sites that 
suffered high and low PD impact during 2005 and 2006 (high impact = 13.8ºC and low impact = 
15.5ºC. Wilcoxon two sample test, P = 0.363). 
 
Days in 10 to 15ºC risk window 
Using water temperature profiles for each site for 2005 and 2006, the number of days that 
seawater was within temperatures of ≥10ºC and ≤15ºC in each site was calculated. Highly 
statistically significant differences were found between average number of days that PD-positive 
sites were in the risk window in comparison with PD-negative sites (PD positive = 129 days and 
PD negative = 119 days. Wilcoxon two sample test, P = 0.008). Highly statistically significant 
differences were also found between groups of high and low PD impact (high impact = 139 days 
and low impact = 122 days. Wilcoxon two sample test, P = 0.007). Tables 7.7 and 7.8 
summarize results from the statistical analysis of continuous variables. 
 
Table 7.7. Continuous data statistical analysis results from 2003, 2004 2005 and 2006 generation 
salmon at sea 

















6.4 2.9 0.016 6.6 6.2 0.468 
Input number 361629 255500 0.347 271344 450000 0.049 
Days to 
outbreak 




_ _ _ 0.9 1.1 0.35 
 
Table 7.8. Continuous data statistical analysis results from 2005 and 2006 generation salmon at 
sea 










Days at risk 
window (10-
15ºC) 
129 119 0.008 122 139 0.007 
Current speeds 
(cm/s) 
38.6 10 0.1695 38.5 47.5 0.457 
Input number 378201 191328 0.0057 280000 492458 0.359 
Temperature at 
PD outbreak 
_ _ _ 15.5 13.8 0.363 
Days to 
outbreak 
_ _ _ 264 134 0.244 
 
 




Similar surveys investigated the epidemiology of PD in Ireland in 2002 (McLoughlin et al., 
2003) and for the period 2003-2004 (Rodger & Mitchell, 2007). The present survey aims to add 
to information regarding the epidemiology of PD, as well as recording aspects of fish health 
status in the Irish salmon industry during the period 2005 to 2007. Since the apparent re-
emergence of PD in Ireland in 2002, the number of operating sites has decreased from 23 to 13 
in 2006. As highlighted by Rodger & Mitchell (2007), the low number of sites in the study is an 
impediment to achieving results that are statistically significant. In order to reduce this problem, 
this study attempted to include as much data from as many different years as possible. Univariate 
statistics were calculated based on the assumption that all sites and years were independent. 
  
The number of sites reporting PD outbreaks increased from 59% (13/22) in 2002 to 86% (12/14) 
in 2004. Data from 2006 year-class, where 69% (9/13) of sites reported PD, suggests a decrease 
in percentage of farms suffering PD. In terms of PD impact, the highest average mortality due to 
PD was reached in 2003 (18.8%) while average mortality due to PD for 2005 and 2006 was 9.8% 
and 9.6% respectively. Data discussed above is featured in Figures 7.1 and 7.2. Although these 
figures show a decreasing trend in number of sites suffering PD and its impact in the period 2004 
to 2007, these differences were not statistically significant.  
 
Although PD does not affect the farms synchronously, the number of PD outbreaks reported 
during the warmer months of the year (June to November) was higher than at any other time. 
Looking at historical data (Figure 7.5), a biphasic presentation was evident with peaks of 
reported number of PD outbreaks in early summer and early autumn. It is possible that the 
influence of certain environmental factors, such as seawater temperature, might have an effect on 
the presentation of outbreaks through the year. In Ireland during 2006, 4/9 (44.4%) outbreaks 
occurred in early summer, with one outbreak reported in August and another in September. No 
biphasic pattern was observed. Interestingly, summer of 2006 was considered to be the warmest 
since 1995, when seawater temperature was above 15ºC from 24th June to 24th September. 
 
Pancreas Disease outbreaks in 2006 were shorter and occurred more acutely. While in 2005 the 
average length of a PD outbreak was 21 weeks (range 12-32), while in 2006 it was only 13 
weeks (range 6-20). Similarly, in 2005 mortalities peaked 15 weeks after first signs on average 
(range 1-32) and only after 5 weeks in 2006 (range 3-6). The PD associated mortality in many 
outbreaks followed the bell shaped curve consistent with an infectious disease. However, in 
some cases more complex curves were present which may reflect multiple factors affecting the 
transmission and impact of the virus on the population or the influence of secondary and/or 
concurrent diseases. 
 
The Salmonid alphavirus does not grow well in vitro above 15ºC, and high water temperatures 
have been considered to have a suppressing role in the presentation of PD outbreaks 
(McLoughlin et al., 1998). Using water temperature profiles for each site in 2005 and 2006, the 
number of days that seawater temperature ranged between 10 and 15ºC was calculated after PD 
diagnosis. This temperature range was considered as a risk window for Atlantic salmon to 
manifest clinical PD and/or present with a higher level of mortality due to PD. Statistically 
significant differences were found between PD-positive and PD-negative sites (P = 0.008) and 
between sites that suffered high and low PD impact (P = 0.007). Results suggested that the 
higher the number of days salmon spent in that risk window, the higher was the risk of 
occurrence and severity of PD. This variable alone or in combination with other variables e.g. 
fish movement, may be helpful for modelling a PD outbreak and predict the likelihood of 
occurrence and its impact for a particular site.  This observation may be of significance and is 
consistent with reports of lower pathogenicity of SAV subtype 2 at 10°C compared to 14°C 
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(Moriette et al., 2006) and as suggested by Graham et al., (2007c) low temperatures may be 
more conducive to sub-clinical spread of the virus, despite prolonged viral survival times. 
 
More than 15% of fish going to sea in Ireland died of gill problems during 2005 and 2006. 
However, PD remains the single most significant infectious disease affecting marine salmon 
farms in Ireland. In agreement with previous observations (Rodger & Mitchell, 2007), data from 
2003 to 2006 had significant differences between bays (P = 0.01) and companies (P = 0.02) with 
a higher prevalence of PD in those bays and companies located in the western counties of Ireland 
(Counties Galway and Mayo). No significant differences were found in terms of PD impact for 
the 2003-2006 period. When data only from 2005 and 2006 was analysed in the same way, no 
statistical differences were found between bays and companies in terms of prevalence of PD and 
its impact. These findings suggest an endemic situation of PD in Ireland. 
 
The stress known to be associated with transporting fish led to livestock movement being 
considered as a potential risk factor for PD. Previous studies showed a positive relationship 
between moving fish during the production cycle and the occurrence of PD. Analysis including 
data from 2003 to 2006 generation showed that fish that were moved during the production cycle 
were 7.85 times more likely to suffer PD (P = 0.001). However, caution in interpreting this 
observation is advised as many companies started to operate summer rearing sites (which 
entailed livestock movement) as a result of recurrent PD outbreaks, hence this observation may 
be a confounding factor. 
 
The four year data also indicates that sites which contract PD and have a higher number of fish 
are more at risk from a higher mortality from PD than those with a lower number of fish on site 
(the high percentage mortality PD sites had mean numbers of 450,000 fish compared to those 
with low percentage mortality which had a mean of 271,344 fish). Although it is not established 
what levels of the virus are required to give rise to a clinical manifestation of PD, it has been 
found that levels of SAV subtypes 1 and 2 in the serum of infected salmonids can be as high as 
1010 TCID50/50μl (Jewhurst et al., 2004) and it can be considered that with higher numbers of 
fish viraemic and multiplying SAV, leading to higher viral shedding and subsequent 
accumulation in the microenvironment of a sea pen is more likely to lead to critical levels of 
viral loading in a farm, which will then overwhelm the natural defences of the fish and be one of 
the factors that leads to more significant clinical disease. 
 
The results reported from this survey assist in the expansion of the knowledge of the 
epidemiology of SAV in farmed salmon. However, practical application of this knowledge is 
more complex and requires application on a site specific or company basis.  
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8. MANAGEMENT & MITIGATION OF PANCREAS DISEASE (WP6) 
 
Neil Ruane, David Graham, Hamish Rodger 
 
8.1 Disinfection against Salmonid alphavirus 
Biosecurity protocols play an important role in preventing disease outbreaks and the spread of 
pathogens both on and between farms. In order to develop effective protocols, fundamental 
information on the biophysical properties of the pathogen in question needs to be determined. In 
the case of the Salmonid alphavirus, a study was undertaken by the Irish Salmon Growers 
Association in conjunction with the Veterinary Sciences Division of Queen’s University Belfast 
to determine the influence of pH, temperature and common disinfectants on virus survival. The 
results of this research have been published (Graham et al., 2007c; 2007d) and the following 
section is a brief overview of the results from that study (see also Appendix III). 
 
Results from the study showed that there was rapid inactivation of the virus (within five minutes 
of exposure), both at a pH of 4 and 12. Inactivation of the virus also occurred after 1 h at a 
temperature of 60oC showing that the virus is susceptible to extremes of pH (low and high) and 
to high temperatures. Therefore, treatment and disposal of dead fish during an outbreak of 
pancreas disease using the common practices of ensiling (low pH), alkaline hydrolysis (high pH) 
or composting (high temperatures) can effectively inactivate the virus. 
 
A range of common disinfectants (Virex, Virkon-S, Halamid (Chloramine-T), Fam 30 and 
Buffodine) were also tested for their ability to inactivate the virus. All disinfectants were found 
to be effective under most of the conditions tested, although some (Fam 30, Buffodine and 
Halamid) had a reduced efficacy in the presence of organic matter emphasising the importance 
of thorough cleaning prior to the application of a disinfectant. 
 
8.2 Management strategies for pancreas disease 
The following sections list some practical measures which are recommended for avoiding 
infection and/or reducing the impact of pancreas disease on a site. 
 
 Monitoring for pancreas disease. 
• A range of diagnostic tools (histological, serological, molecular) are now available to 
monitor populations for infection and regular screening of the farm stock is advised. 
Use of these tools allows infection to be rapidly identified and appropriate mitigation 
factors put in place, prior to a major mortality event. 
• Monitor the sea lice burden (weekly) and treat before clinical problems develop. 
 
Recommendations specific to pancreas disease. 
• Maintain a high level of site biosecurity with emphasis on personnel, visitors and 
equipment. Evidence to date suggests that horizontal rather than vertical transmission 
is responsible for the spread of infection in Ireland. 
• If recovered populations are indeed a source of infection for naïve fish then efforts 
should be made to avoid overlapping these populations at a farm or bay level. 
Adherence to single bay management strategies are therefore encouraged. 
• Fast fish for 5 to 10 days on a pen-by-pen basis if pancreas disease is detected at an 
early stage. 
• If myopathies are significant then fish should be fasted during periods of spring 
tides/periods of strong currents. 
• Mortality removal should be frequent (ideally daily with use of lift-up type systems). 
 






















8.3 Recommendations for future research 
The Pancreas Disease Tri-nation group carried out a recent exercise to identify knowledge gaps 
and proposed areas of future research with regards to pancreas disease and the Salmonid 
alphavirus. Outputs from this exercise together with specific recommendations from this project 
are shown below. 
 
Table 8.1. Areas for future research related to pancreas disease. 
Objectives RTDI Requirements Key Outputs 
Selective breeding 
for PD resistance. 
Identification of susceptible/resistant traits. 








Production of more antibodies specific to SAV. 
Development of practical and rapid diagnostic tests. 
Work on standardisation, validation and 
accreditation of diagnostic methods. 
Application of microarray technologies. 
Increased availability 
of diagnostic tests for 
the rapid identification 
of SAV infections. 
Increased 
knowledge of the 
salmonid 
alphavirus. 
Increased knowledge on the 
virulence/pathogenicity of virus sub-types through 
sequencing and infection studies. 
Improvement of experimental transmission models. 
Improved knowledge of the disease cycle 
(transmission mechanisms, reservoirs, role of wild 
fish, disease triggers). 







treatment of the 
disease. 
Development of more effective vaccines. 
Investigations into the effectiveness of PD diets and 
immunostimulants. 
Epidemiological studies to include meta-analysis 
from different countries, molecular epidemiology, 
modelling. 
Effectiveness of area management strategies. 
Reduction of losses 
during and outbreak of 
pancreas disease. 
 
Recommendations for the mitigation of pancreas disease. 
• Specialised PD diets or functional foods should be utilised (when at risk or after 
confirmation of PD) which are more easily digestible, have higher micronutrient 
(antioxidants and vitamins) levels as well as immunostimulants. 
• Select strains of fish suitable for sea site. 
• Vaccinate all stock against pancreas disease (results of new vaccine pending). 
 
General recommendations. 
• Each site should adhere to the recommendations in their Fish Health Management 
Plan. 
• Maintain a high standard of pen environment i.e. keep nets clean and maintain optimal 
oxygen levels (aerate or oxygenate during periods of low dissolved oxygen). 
• Feed fish to tables or set farm percentage and not to appetite i.e. do not allow fish to 
gorge themselves. 
• Where possible avoid management practices that will stress sick fish (e.g. movements, 
net changes) 
• Mortality removal should be frequent (ideally daily with use of lift-up type systems). 









• Pancreas disease is endemic in marine farmed Atlantic salmon in Ireland, but no 
evidence of infection in rainbow trout has been found. 
• Screening of fish stocks for pancreas disease should be based on serological and/or 
molecular based methods. 
• Confirmation of a clinical outbreak of pancreas disease should be based on site 
mortality figures, histopathology and serological and/or molecular methods as 
confirmatory tests. 
• Seawater temperatures may play an important role in determining the length and 
severity of a pancreas disease outbreak. 
• Survivors of a pancreas disease outbreak remain antibody positive against the virus for 
the remainder of the production cycle, thus are unlikely to get reinfected. 
• Survivors of a pancreas disease outbreak can potentially act as a source of infection for 
naïve fish. 
• No evidence was found to suggest that sea lice and mussels can transmit the virus. 
• Although vertical transmission of the virus cannot be ruled out, it is likely that 
horizontal transmission of the virus between fish and adjacent sites is the primary route 
of infection. 
• Strict biosecurity protocols and an adherence to the principles of single bay 
management are recommended. 
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APPENDIX I. Project Outputs 
 
Pancreas disease meetings supported by the project ST/05/01. 
Meeting Date Place 
Initial project meeting 15.11.2005 MI, Galway 
Tri-nation 01.02.2006 Oslo 
Project 26.05.2006 MI, Galway 
Tri-nation 21-22.09.2006 MI, Galway 
Project 06.12.2006 MI, Galway 
Tri-nation 19-20.04.2007 Aberdeen 
Project 31.05.2007 MI, Galway 
Tri-nation 15-16.11.2007 Bergen 
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APPENDIX II Sampling protocol for longitudinal studies. 
 
Sampling was conducted every 14 days, from each set of 20 fish, the following samples were 
collected: 
 
Sample Type Sample ID Molecular Virology Histology
Heart H √ √ √ 
Anterior kidney K √ √ √ 
Brain B √ √ √ 
Pyloric caecae C √ √ √ 
Pseudobranch P √  √ 
Gill G √ √ √ 
Lateral line muscle M   √ 
Serum S √ √  
Lice LC (Caligus) 
LL (Lepeophtheirus) 
√   
 
PROTOCOL 
Sampling tissues to RNAlater® (molecular) 
• From each fish take a sample of heart approximately 0.5cm x 0.5cm x 0.5cm in size. 
• Place in a 1.5 mL plastic tube containing 1 mL RNAlater® (supplied pre-dispensed).  
• Label with sample identifier (H), FHU reference number and fish number. 
• Repeat for other tissues, using a separate tube for each tissue. 
• If lice are present on an individual fish, sample a maximum of 10 lice. If both species are 
present, place in separate vials, labelled with fish number and species and the species of 
lice as given above. 
 
Sampling tissues for virus isolation and histology 
• Virology: 
o From each fish take a sample of heart tissue (>0.5g [1cm x 1cm x 0.5cm) and 
place in a falcon tube containing 4 mL transport medium and label with FHU 
reference number and fish number. 
o Repeat for other tissues, placing all tissues from the same fish in the same tube. 
• Histology 
o From first 5 fish (10 if clinical signs) sample as above, placing all tissues from 
each fish in the same formalin pot. Pyloric caecae/pancreas, heart and muscle will 
be processed initially, with the other samples stored until PD has been diagnosed. 
 
Sampling serum 
• Take 0.5 – 1 mL blood from each fish. 
• Allow red cells to clot/settle (e.g. 4ºC overnight). 
• Centrifuge sample and remove serum to a blood tube labelled with FHU reference 
number and fish number. 
• NB Avoid haemolysis during sample collection/processing. 
 
Shellfish 
10 mussels should be taken from each cage from which fish are being sampled on a given day, 
placed in a labelled bag (cage, species, date). 
 
Storage 
Formalin samples should be stored in the dark at room temperature. 
The remainder of the samples should be stored at –20ºC or below. 
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APPENDIX III. A summary of disinfection data for Salmonid alphavirus based on 
Graham et al. (2007c; 2007d). 
 
Method Dose Result 
Heat 60°C for 1 hour Inactivation 
Acid pH 4 for 5 mins Inactivation 
Alkaline pH 12 for 5 mins Inactivation 
Peroxygen compounds (Virex, 
Virkon*) 
0.5 – 2%; 4 or 10oC Inactivation (5 – 30 mins) 
Chloramine T (Halamid) $ 0.5 – 2%; 4 or 10oC Inactivation (5 – 30 mins) 
Iodophors (FAM 30, Vanodine)$ 1/600 – 1/125; 10oC Inactivation (30 mins) 
Buffered iodophors (Buffodine)#, $ 1 – 2%;10oC Inactivation (30 mins) 
* Forms a precipitate when dissolved in seawater, therefore no testing was performed in 
seawater. 
# Not tested in seawater. 
$ Reduced efficacy in the presence of organic material. 
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APPENDIX IV. Tri-Nation Seminar Agenda (September 2006).  
 
5th Tri-Nation Seminar on Pancreas Disease & Related Pathologies 
20 – 21 September 2006 
North Atlantic Drift Auditorium 
Marine Institute, Galway, Ireland 
20 September 2006  
Introduction  
(G. Ritchie,  Marine Harvest ASA; M. Ó Cinnéide, Marine Institute) 09.15 – 10.00 
- minutes from Oslo Tri-Nation Meeting, 1 Feb 2006 
- PD update 2006 + meeting objectives 
 
Session I. Project Updates & Practical Outputs 
I.I Epidemiology (E. Brun, National Veterinary Institute; M. Sandberg, Norwegian School of 
Veterinary Science)        10.00 – 11.15 
 - inc. update on Norway, Scotland 
 - Ireland (H. Rodger, Vet-Aqua Int.) 
 
I.II Aetiology & Longitudinal Studies (D. Graham, AFBINI)  11.30 – 12.45 
 - inc. Marine Harvest study (C. Wallace, Marine Harvest Scotland) 
 
I.III General Diagnostics (H. Sindre, National Veterinary Institute)  12.45 – 13.30 
- inc. SARF project in Scotland (J. Costa, Stirling Univ.)  
Lunch     13.30 – 14.30 
 
Session II. Update on Related Pathologies & Research Projects (N. Ruane, MI) 
Recent Norwegian projects to support management and control of PD 
Ase-Helen Garseth (VESO)     15.00 – 15.30 
Salmon Heart Diseases: HSS, HSMI, CMS, and SAV disease 
Are Nylund (University of Bergen)    15.30 – 16.00 
Research update on Heart & Skeletal Muscle Inflammation 
Oystein Evensen (Norwegian School of Vet. Sci.)  16.15 – 16.45 
    
21 September 2006 
Session II (cont). Update on Related Pathologies & Research Projects (N. Ruane, MI) 
Heritability of mortality in response to a natural PD challenge in salmon post-smolts  
Ashie Norris (Marine Harvest Ireland)   9.15 – 9.45 
Biophysical properties of SAV 
David Graham (AFBINI/QUB)     9.45 – 10.15 
Vertical transmission studies of SPDV  
J. Castric (AFSSA, France)     10.15 – 10.45 
Q-PCR assay for gene expression studies during SAV infection in salmonid cell lines 
Marius Karlsen (University of Bergen)   10.45 – 11.15 
   
Session III: Future Projects & Funding (N. Ruane MI; B. Hjeltnes, National Veterinary 
Institute)         11.30 – 13.30 
- discussion on FP7 funding 
- other projects/focus areas/issues 
- conclusions & actions 
Lunch     13.30 – 14.30 
Session IV: Wrap Up (G. Ritchie MH; M. O Cinnéide MI) 
- milestone reporting; overview, publication in trade press   14.30 – 15.30 
- next meeting 
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APPENDIX V. Tri-Nation Seminar Attendees (September 2006).  
 
 Name Institute/Company 
1 Gordon Ritchie Marine Harvest ASA 
2 Neil Ruane Marine Institute, Ireland 
3 Micheal O Cinneide Marine Institute, Ireland 
4 Fiona Geoghegan Marine Institute, Ireland 
5 Catherine Henderson Marine Institute, Ireland 
6 David Graham Agri-Food & Biosciences Institute, N. Ireland 
7 Helen Rowley Agri-Food & Biosciences Institute, N. Ireland 
8 Heather Jewhurst Agri-Food & Biosciences Institute, N. Ireland 
9 Kim Cherry Agri-Food & Biosciences Institute, N. Ireland 
10 Claire Wilson Agri-Food & Biosciences Institute, N. Ireland 
11 Tracy Clegg University College Dublin, Ireland 
12 Leo Foyle University College Dublin, Ireland 
13 Hamish Rodger Vet-Aqua International, Ireland 
14 Albert Girons Vet-Aqua International, Ireland 
15 Ashie Norris Marine Harvest Ireland 
16 Marian McLoughlin Aquatic Vet. Services, N. Ireland 
17 Olav Breck Marine Harvest Norway 
18 John Finlay Nutreco 
19 Andy Reeve AquaGen/Nor West Aqua, Scotland 
20 Ronald Roberts University of Idaho/Landcatch, Scotland 
21 Chris Mitchell Landcatch, Scotland 
22 Ed Branson Fish Veterinary Society, England 
23 David Bruno Fisheries Research Services, Scotland 
24 Trevor Hastings Fisheries Research Services, Scotland 
25 Kjell Maroni Norwegian Seafood Federation 
26 Are Nylund University of Bergen, Norway 
27 Marius Karlsen University of Bergen, Norway 
28 Kjartan Hodneland University of Bergen, Norway 
29 Kim Thompson University of Stirling, Scotland 
30 Janina Costa University of Stirling, Scotland 
31 Øystein Evensen Norwegian School of Veterinary Science 
32 Jeanette Castric AFSSA, France 
33 Karen Elina Christie Intervet, Norway 
34 Marianne Sandberg Norwegian School of Veterinary Science 
35 Edgar Brun National Veterinary Institute, Norway 
36 Brit Hjletnes National Veterinary Institute, Norway 
37 Hilde Sindre National Veterinary Institute, Norway 
38 Christian Wallace VESO Vikan, Norway 
39 Åse Helen Garseth VESO Trondheim, Norway 
40 David Stone CEFAS, England 
41 Dave Cockerill Marine Harvest Scotland 
42 Alasdair MacLennan Marine Harvest Scotland 
43 Chris Wallace Marine Harvest Scotland 
44 Carol Cox Marine Harvest Scotland 
45 Catherine McManus Marine Harvest Ireland 
46 Karen McCrann Mannin Bay Salmon Company, Ireland 
47 Joe McElwee Irish Salmon Growers’ Association 
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48 Abdon Ryan Celtic Atlantic, Ireland 
49 Damien Ó Ceallachain Meitheal Eisc Teo., Ireland 
50 Daragh Ó Fhlatharta Eisc Ui Fhlatharta, Ireland 
51 Louise Collins Bord Iascaigh Mhara, Ireland 
52 Joe Lee Meitheal Eisc Teo., Ireland 
53 Patrick Smith Schering Plough Aquaculture, England 
54 Declan Clarke National University of Ireland, Galway 
55 Gery Flynn Inshore Ireland 
56 Aengus Parsons Marine Institute, Ireland 
57 Laura Hogan Marine Institute, Ireland 
58 Michelle Geary Marine Institute, Ireland 
59 David Swords Marine Institute, Ireland 
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APPENDIX VI. Tri-Nation Seminar Agenda (May 2008).  
8th Tri-Nation PD(+) seminar  
7 – 8 May, 2008 
Marine Institute, Galway 
Seminar Programme 
 
Wednesday May 7 
Introduction and overview of the Tri-Nation consortium    9.15 – 9.30 
 Neil Ruane (Marine Institute) & Gordon Richie (Marine Harvest ASA) 
 
Session 1. Scene setting (Chair: Neil Ruane) 
“Update on pancreas disease in Scotland”  
Sandy Murray, FRS Aberdeen     9.30 – 9.50 
“Update on pancreas disease in Ireland”  
Hamish Rodger, Vet-Aqua International    9.50 – 10.10 
“Update on pancreas disease in Norway”   
Anne Berit Olsen, National Veterinary Institute, Norway  10.10–10.30 
 
Session 2. Research Presentations (Chair: David Graham) 
“Descriptive results from the Norwegian cohort study”  
Mona Jansen, Norwegian School of Veterinary Sciences  10.30–11.00 
COFFEE 11.00 – 11.30 
 “A longitudinal study of PD in Ireland” 
  David Graham, Agri-Food & Biosciences Institute   11.30–11.50 
“Modelling risk factors for outbreaks of HSMI and PD in Norway”  
Anja Kristoffersen, NVI      11.50–12.10 
“Modelling sea currents and risks of disease transmission among aquaculture sites”  
Hildegunn Viljugrein, NVI      12.10–12.30 
“Isolation of Salmonid alphavirus from sea lice”  
Marianne Sandberg, NSVS       12.30–12.50 
“PD work at the Institute of Aquaculture, University of Stirling: An Update” 
 Tharangani Herath, Kim Thompson, Alexandra Adams, Randolph Richards 
           12.50–13.10 
LUNCH 13.10 – 14.00 
 “Experimental transmission of cardiomyopathy in Atlantic salmon” 
  David Bruno, FRS Aberdeen      14.00–14.20 
“Experimental transmission of CMS in Atlantic salmon”  
Camilla Fritsvold, NVI      14.20–14.45 
“Studies on experimental transmission of HSMI”  
Ruth Torill Kongtorp, NVI      14.45–15.10 
Open discussion          
           15.10–15.30 
COFFEE 15.30 – 16.00 
Extra Session. Gill Pathologies (Chair: Gordon Ritchie) 
An extra session will be included to discuss the issues related to gill pathologies and interest in 
developing a similar Tri-Nation approach to dealing with the problem will be sought.  
 
Presentations & open discussion       16.00–17.30 
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Thursday May 8 
 
Session 3. Open session: Industry Research Projects (Chair: Gordon Richie) 
“Radical change is inevitable to combat PD”  
Cato Lyngoy, Marine Harvest Norway     9.15 – 9.35 
“Unexpected challenges with real-time PCR analyses on PDV-vaccinated fish”  
Vidar Auspehaug, Patogen       9.35 – 9.55 
“PD vaccination: additional methods for efficacy evaluation” 
 Petter Frost, Intervet        9.55 – 10.15 
“React PD: dietary mitigation”  
Charles McGurk, Skretting.       10.15–10.35 
“Assessing the efficacy of a PD diet”  
Adel El-Mowafi, EWOS Innovation; Marianne Sandberg, NSVS  10.35–10.55 
COFFEE 10.55 – 11.20 
Session 4. Expert panel  (Chair: Micheal Ó Cinneide) 
An expert panel will be put together to answer questions from the industry in relation to 
pancreas disease.         11.20–12.20 
 
“Closing discussion” Gordon Richie (Marine Harvest ASA) & Micheal Ó Cinneide (Marine 
Institute)          12.20–13.15 
LUNCH 13.15 – 14.00 
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APPENDIX VII. Tri-Nation Seminar Attendees (May 2008). 
 Name Institute/Company 
1 Gordon Ritchie Marine Harvest ASA 
2 Neil Ruane Marine Institute, Ireland 
3 Micheal Ó Cinneide Marine Institute, Ireland 
4 Kathy Henshilwood Marine Institute, Ireland 
5 Oonagh McMeel Marine Institute, Ireland 
6 Stephen McCleary Marine Institute, Ireland 
7 Cathy Hickey Marine Institute, Ireland 
8 Lorraine McCarthy Marine Institute, Ireland 
9 Marcel Curé Marine Institute, Ireland 
10 Hamish Rodger Vet Aqua International, Ireland 
11 Susan Mitchell Vet Aqua International, Ireland 
12 Louise Henry Vet Aqua International, Ireland 
13 David Graham Agri-Food & Biosciences Institute, N. Ireland 
14 Marian McLoughlin Aquatic Veterinary Services, N. Ireland 
15 Iain Shaw National University of Ireland, Galway 
16 Tom Doyle University College Cork, Ireland 
17 Damien Ó Ceallachain Meitheal Eisc Teo., Ireland 
18 Joe Lee Meitheal Eisc Teo., Ireland 
19 Abdon Ryan Celtic Atlantic, Ireland 
20 Gery Flynn Inshore Ireland 
21 Isabel Valera Bord Iascaigh Mhara, Ireland 
22 Cato Lyngøy Marine Harvest Norway 
23 Anne Berit Olsen National Veterinary Institute, Norway 
24 Edgar Brun National Veterinary Institute, Norway 
25 Torunn Taksdal National Veterinary Institute, Norway 
26 Camilla Fritsvold National Veterinary Institute, Norway 
27 Ruth Torill Kongtorp National Veterinary Institute, Norway 
28 Hildegunn Viljugrein National Veterinary Institute, Norway 
29 Marianne Sandberg Norwegian School of Veterinary Science 
30 Mona Jansen Norwegian School of Veterinary Science 
31 Anja Kristoffersen Norwegian School of Veterinary Science 
32 Linda Andersen University of Bergen, Norway 
33 Kjell Maroni Norwegian Seafood Federation 
34 Rudi Seim Immunocorp, Norway 
35 Petter Frost Intervet, Norway 
36 Andre Bratland Havbruksinstituttet, Norway 
37 Vidar Auspehaug Patogen, Norway 
38 Magnus Devold Patogen, Norway 
39 Charles McGurk Skretting, Norway 
40 Adel El-Mowafi EWOS Innovation, Norway 
41 Marie Egenberg Pharmaq, Norway 
42 David Bruno Fisheries Research Services, Scotland 
43 Patricia Noguera Fisheries Research Services, Scotland 
44 Sandy Murray Fisheries Research Services, Scotland 
45 Randolph Richards University of Stirling, Scotland 
46 Darren Green University of Stirling, Scotland 
47 Kim Thompson University of Stirling, Scotland 
48 Chris Mitchell Landcatch, Scotland 




1. O'Donohoe, G., Hensey, M., O'Connor, B. (2000) Assessment of Water Quality Data from Kilkieran Bay, Co. Galway.
2. McGovern, E., Rowe, A., McHugh, B., Costello, J., Bloxham, M., Duffy, C., Nixon, E. (2001) Trace Metal and Chlorinated Hydrocarbon
Concentrations in Shellfish from Irish Waters, 1997-1999.
3. Coyne, R., Smith, P., Moriarty, C. (2001) The Fate of Oxytetracycline in the Marine Environment of a Salmon Cage Farm.
4. McGovern, E., Monaghan, E., Bloxham, M., Rowe,A., Duffy, C., Quinn,A., McHugh, B., McMahon,T., Smyth, M., Naughton, M., McManus, M., Nixon,
E. (2002) Winter Nutrient Monitoring of the Western Irish Sea - 1990 to 2000.
5. Minchin, D., Lucy, F., Sullivan, M. (2002) Monitoring of Zebra Mussels in the Shannon-Boyle Navigation, Other Navigable Regions and Principal
Irish Lakes, 2001 & 2002.
6. Minchin, D. (2003) Monitoring of Tributyl Tin Contamination in Six Marine Inlets using Biological Indicators.
7. Glynn, D., Tyrrell, L., McHugh, B., Rowe, A., Costello, J., McGovern, E. (2003) Trace Metal and Chlorinated Hydrocarbon Concentrations in
Shellfish from Irish Waters, 2000.
8. Tyrrell, L., Glynn, D., Rowe, A., McHugh, B., Costello, J., Duffy, C., Quinn, A., Naughton, M., Bloxhan, M, Nixon, E., McGovern, E. (2003) Trace
Metal and Chlorinated Hydrocarbon Concentrations in Various Fish Species, Landed at Selected Irish Ports, 1997-2000.
9. Telfor,T. & Robinson, K. (2003) Environmental Quality and Carrying Capacity for Aquaculture in Mulroy Bay Co. Donegal.
10. Glynn, D., Tyrell, L., McHugh, B., Rowe, A., Monaghan , E., Costello, J., McGovern, E. (2003) Trace Metal and Chlorinated Hydrocarbon
Concentrations in Shellfish from Irish Waters, 2001.
11. Grehan,A., Long, R., Deegan, B., O'Cinneide, M. (2003) The Irish Coral Task Force and Atlantic Coral Ecosystem Study Report on Two deep-
Water Coral Conservation Stakeholder Workshops held in Galway in 2000 and 2002.
12. McHugh, B., Glynn, D., Nixon, E., McGovern, E. (2003) The Occurrence and Risk Assessment of the Pesticide Toxaphene in Fish from Irish
Waters 2003.
13. Tyrrell, L., Glynn, D., McHugh, B., Rowe, A., Monaghan, E., Costello, J., McGovern, E. (2003) Trace Metal and Chlorinated Hydrocarbon
Concentrations in Various Fish Species Landed at Selected Irish Ports, 2001.
14. McLoughlin, M.F., Peeler, E., Foyle, K.L., Rodger, H.D., O'Ceallachain, D., Geoghegan, F. (2003) An Epidemiological Investigation of the Re-
emergence of Pancreas Disease in Irish Farmed Atlantic Salmon (Salmo Salar L.) in 2002.
15. Cronin, M., Cusack, C., Geoghegan, F., Jackson, D., McGovern, E., McMahon,T., O'Beirn, F., O'Cinneide M., Silke, J. (2004) Salmon Mortalities
at Inver Bay and McSwynes Bay Finfish Farms, County Donegal, Ireland during 2003.
16. Glynn, D.,Tyrrell, L., McHugh, B., Monaghan, E., Costello, J., McGovern, E. (2004) Trace Metal and Chlorinated Hydrocarbon Concentrations
in Shellfish from Irish waters, 2002. .
17. Werner,A. Kraan, S.(2004) Review of the Potential Mechanisation of Kelp Harvesting in Ireland.
18. Tyrrell, L., Twomey, M., Glynn, D., McHugh, B., Joyce, E., Costello, J., McGovern, E. (2004) Trace Metal and Chlorinated Hydrocarbon
Concentrations in Various Fish Species Landed at Selected Irish Ports, 2002.
19. (2005) Proceedings of the 5th Irish Shellfish Safety Scientific Workshop.
20. Tyrrell L., McHugh B., Glynn D.,Twomey M., Joyce E., Costello J., McGovern E. (2005) Trace Metal Concentrations in Various Fish Species
Landed at Selected Irish Ports 2003.
21. Silke J., O Beirn, F., Cronin M. (2005) Karenia mikimotoi:An Exceptional Dinoflagellate Bloom in Western Irish Waters - Summer 2005.
22. Ruane, N., Graham, D., Foyle, L, Norris,A., Ratcliff, J., Murphy, K. Mitchell, S. Staples, C., Jewhurst, H.,Todd, D., Geoghegan, F. & O’Cinneide, M.
(2005) Research on Pancreas Disease in Irish Farmed Salmon 2004/2005 - Current and Future Initiatives.
23. (2006) Proceedings of the 6th Irish Shellfish Safety Scientific Workshop.
24. Cronin M., McGovern E., McMahon T. Boelens R. (2006) Guidelines For The Assessment of Dredge Material For Disposal In Irish Waters.
25. Boyle B.,Tyrrell L., McHugh B., Joyce E., Costello J., Glynn D., McGovern E. (2006) Trace Metal Concentrations in Shellfish from Irish Waters,
2003.
26. Tlustos C., McHugh, B., Pratt. I., Tyrrell L., McGovern E. (2006) Investigation into Levels of Dioxins, Furans, Polychlorinated Biphenyls and
Brominated Flame Retardants in Fishery Produce in Ireland.
27. (2007) Proceedings from the 7th Irish Shellfish Safety Workshop.
28. Hess P., McCarron P, Rehmann N., Kilcoyne J., McMahon T., Ryan G., Ryan, M.P.,Twiner M. J., Doucette G.J., Satake M., Ito E.,Yasumoto T. (2007)
Isolation and Purification of AZAs from Naturally Contaminated Materials, and Evaluation of their Toxicological Effects (ASTOX).
29. Culloty S. & Mulcahy M. (2007) Bonamia ostrea in the Native Oyster Ostrea edulis:A Review.
30. Ruane N., Geoghegan F., O’Cinneide M. (2007) Infectious Pancreatic Necrosis Virus and its Impact on the Irish Salmon Aquaculture and Wild
Fish Sectors.
31. Maguire J.A., Knights T. Burnell G., Crowe,T., O’Beirn, F., McGrath, D., Ferns M., McDonough, N., McQuaid N., O’Connor, B., Doyle R., Newell
C., Seed R., Smaal,A., O’Carroll,T.,Watson L., Dennis J., O’Cinneide M. (2007) Management Recommendations for the Sustainable Exploitation
of Mussel Seed in the Irish Sea.
32. O’Mahony C., Sutton G., McMahon T., Ó’Cinnéide M., Nixon E. (2008) Issues and Recommendations for the Development and Regulation
of Marine Aggregate Extraction in the Irish Sea.




PANCREAS DISEASE IN FARMED SALMON -
HEALTH MANAGEMENT AND INVESTIGATIONS
AT IRISH FARM SITES 2005 - 2008





Tel: +353 1 476 6500





Tel: +353 98 42300





Tel: +353 91 387 200
Fax: +353 91 387 201
Email: institute.mail@marine.ie
MARINE INSTITUTE REGIONAL OFFICESHEADQUARTERS & LABORATORIES
